• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Cadre Holdings Inc.

    5/6/25 4:17:42 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    CADRE HOLDINGS, INC._March 31, 2025
    0001860543--12-312025Q1false0040607988http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent406595850.360001860543us-gaap:RetainedEarningsMember2025-03-310001860543us-gaap:AdditionalPaidInCapitalMember2025-03-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001860543us-gaap:RetainedEarningsMember2024-12-310001860543us-gaap:AdditionalPaidInCapitalMember2024-12-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001860543us-gaap:RetainedEarningsMember2024-03-310001860543us-gaap:AdditionalPaidInCapitalMember2024-03-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001860543us-gaap:RetainedEarningsMember2023-12-310001860543us-gaap:AdditionalPaidInCapitalMember2023-12-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001860543us-gaap:CommonStockMember2025-01-012025-03-310001860543us-gaap:CommonStockMember2024-01-012024-03-310001860543us-gaap:OverAllotmentOptionMember2024-04-010001860543cdre:SecondaryOfferingMember2024-03-190001860543cdre:AlphaSafetyIntermediateLlcMember2025-01-012025-03-3100018605432026-04-012025-03-3100018605432025-04-012025-03-310001860543us-gaap:NonUsMember2025-01-012025-03-310001860543country:US2025-01-012025-03-310001860543cdre:U.s.stateAndLocalAgenciesMember2025-01-012025-03-310001860543cdre:U.s.FederalAgenciesMember2025-01-012025-03-310001860543cdre:OtherMember2025-01-012025-03-310001860543cdre:InternationalMember2025-01-012025-03-310001860543cdre:CommercialMember2025-01-012025-03-310001860543us-gaap:NonUsMember2024-01-012024-03-310001860543country:US2024-01-012024-03-310001860543cdre:U.s.stateAndLocalAgenciesMember2024-01-012024-03-310001860543cdre:U.s.FederalAgenciesMember2024-01-012024-03-310001860543cdre:OtherMember2024-01-012024-03-310001860543cdre:InternationalMember2024-01-012024-03-310001860543cdre:CommercialMember2024-01-012024-03-310001860543cdre:CarrSGroupPlcEngineeringDivisionMembercdre:DelayedDrawTermLoanA1FacilityMemberus-gaap:SubsequentEventMember2025-04-012025-04-300001860543us-gaap:InterestRateSwapMember2025-01-012025-03-310001860543us-gaap:ForeignExchangeForwardMember2025-01-012025-03-310001860543us-gaap:InterestRateSwapMember2024-01-012024-03-310001860543us-gaap:ForeignExchangeForwardMember2024-01-012024-03-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001860543us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001860543srt:MinimumMembercdre:CanadianCreditFacilityMember2021-10-142021-10-140001860543srt:MaximumMembercdre:CanadianCreditFacilityMember2021-10-142021-10-140001860543cdre:CarrSGroupPlcEngineeringDivisionMembercdre:DelayedDrawTermLoanA1FacilityMemberus-gaap:SubsequentEventMember2025-04-300001860543us-gaap:RevolvingCreditFacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543us-gaap:LetterOfCreditMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543cdre:SwingLineLoansMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543cdre:DelayedDrawTermLoanA2FacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543cdre:DelayedDrawTermLoanA1FacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543us-gaap:LetterOfCreditMembercdre:CanadianCreditFacilityMember2021-10-140001860543us-gaap:RevolvingCreditFacilityMembercdre:CanadianCreditFacilityMember2025-03-310001860543us-gaap:RevolvingCreditFacilityMembercdre:CanadianCreditFacilityMember2024-12-310001860543us-gaap:LetterOfCreditMembercdre:AmendedAndRestatedCreditAgreementMember2025-03-310001860543srt:MaximumMember2025-03-310001860543cdre:CashFlowHedgesMember2025-03-310001860543us-gaap:TradeNamesMember2025-03-310001860543us-gaap:TradeNamesMember2024-12-310001860543cdre:ProductsMember2025-01-012025-03-310001860543cdre:ProductsMember2025-03-310001860543cdre:DistributionServicesMember2025-03-310001860543cdre:ProductsMember2024-12-310001860543cdre:DistributionServicesMember2024-12-310001860543us-gaap:TradeNamesMember2025-03-310001860543us-gaap:TechnologyBasedIntangibleAssetsMember2025-03-310001860543us-gaap:NoncompeteAgreementsMember2025-03-310001860543us-gaap:CustomerRelationshipsMember2025-03-310001860543us-gaap:TradeNamesMember2024-12-310001860543us-gaap:TechnologyBasedIntangibleAssetsMember2024-12-310001860543us-gaap:NoncompeteAgreementsMember2024-12-310001860543us-gaap:CustomerRelationshipsMember2024-12-310001860543us-gaap:RetainedEarningsMember2025-01-012025-03-310001860543us-gaap:RetainedEarningsMember2024-01-012024-03-310001860543cdre:OtherLiabilitiesNoncurrentMemberus-gaap:InterestRateSwapMember2024-12-310001860543cdre:AccruedLiabilitiesCurrentMemberus-gaap:InterestRateSwapMember2024-12-310001860543cdre:OtherLiabilitiesNoncurrentMemberus-gaap:InterestRateSwapMember2025-03-310001860543cdre:AccruedLiabilitiesCurrentMemberus-gaap:InterestRateSwapMember2025-03-310001860543cdre:InterestRateSwapTwoMember2025-03-310001860543cdre:InterestRateSwapThreeMember2025-03-310001860543cdre:InterestRateSwapOneMember2025-03-310001860543us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001860543us-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2025-03-310001860543cdre:OtherAssetsNoncurrentMemberus-gaap:InterestRateSwapMember2025-03-310001860543us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001860543us-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2024-12-310001860543cdre:OtherAssetsNoncurrentMemberus-gaap:InterestRateSwapMember2024-12-310001860543cdre:InterestRateSwapTwoMember2025-01-012025-03-310001860543cdre:InterestRateSwapThreeMember2025-01-012025-03-310001860543cdre:InterestRateSwapOneMember2025-01-012025-03-310001860543cdre:TermLoanMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543us-gaap:RevolvingCreditFacilityMembercdre:AmendedAndRestatedCreditAgreementMember2025-03-310001860543us-gaap:RevolvingCreditFacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-310001860543srt:MinimumMembercdre:AmendedAndRestatedCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-12-202024-12-200001860543srt:MinimumMembercdre:AmendedAndRestatedCreditAgreementMemberus-gaap:BaseRateMember2024-12-202024-12-200001860543srt:MaximumMembercdre:AmendedAndRestatedCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-12-202024-12-200001860543srt:MaximumMembercdre:AmendedAndRestatedCreditAgreementMemberus-gaap:BaseRateMember2024-12-202024-12-200001860543srt:MinimumMembercdre:CanadianCreditFacilityMemberus-gaap:BaseRateMember2021-10-142021-10-140001860543srt:MinimumMembercdre:CanadianCreditFacilityMembercdre:LondonInterbankOfferedRateMember2021-10-142021-10-140001860543srt:MaximumMembercdre:CanadianCreditFacilityMemberus-gaap:BaseRateMember2021-10-142021-10-140001860543srt:MaximumMembercdre:CanadianCreditFacilityMembercdre:LondonInterbankOfferedRateMember2021-10-142021-10-140001860543us-gaap:OperatingSegmentsMembercdre:ProductsMember2025-01-012025-03-310001860543us-gaap:OperatingSegmentsMembercdre:DistributionServicesMember2025-01-012025-03-310001860543us-gaap:MaterialReconcilingItemsMember2025-01-012025-03-310001860543us-gaap:OperatingSegmentsMembercdre:ProductsMember2024-01-012024-03-310001860543us-gaap:OperatingSegmentsMembercdre:DistributionServicesMember2024-01-012024-03-310001860543us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310001860543us-gaap:CommonStockMember2025-03-310001860543us-gaap:CommonStockMember2024-12-310001860543us-gaap:CommonStockMember2024-03-310001860543us-gaap:CommonStockMember2023-12-3100018605432024-03-3100018605432023-12-310001860543us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001860543us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001860543cdre:AlphaSafetyIntermediateLlcMember2024-02-292024-02-290001860543cdre:IcorTechnologyInc.Memberus-gaap:MeasurementInputDiscountRateMember2024-01-090001860543cdre:IcorTechnologyInc.Member2025-03-310001860543cdre:IcorTechnologyInc.Member2024-12-310001860543srt:MaximumMembercdre:BasedOnFutureCumulativeNetSalesDuringThreeYearPeriodEndedJanuary92027Membercdre:IcorTechnologyInc.Member2024-01-090001860543cdre:CarrSGroupPlcEngineeringDivisionMemberus-gaap:SubsequentEventMember2025-04-012025-04-300001860543cdre:IcorTechnologyInc.Member2024-01-092024-01-090001860543us-gaap:InterestRateSwapMember2025-03-310001860543us-gaap:ForeignExchangeForwardMember2025-03-310001860543us-gaap:InterestRateSwapMember2024-12-310001860543us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001860543us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001860543cdre:AlphaSafetyIntermediateLlcMemberus-gaap:TrademarksMember2024-02-292024-02-290001860543cdre:AlphaSafetyIntermediateLlcMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-02-292024-02-290001860543cdre:AlphaSafetyIntermediateLlcMemberus-gaap:CustomerRelationshipsMember2024-02-292024-02-290001860543cdre:IcorTechnologyInc.Memberus-gaap:TrademarksMember2024-01-092024-01-090001860543cdre:IcorTechnologyInc.Memberus-gaap:TechnologyBasedIntangibleAssetsMember2024-01-092024-01-090001860543cdre:IcorTechnologyInc.Memberus-gaap:CustomerRelationshipsMember2024-01-092024-01-0900018605432025-05-020001860543cdre:KandersCompanyIncMember2025-01-012025-03-310001860543cdre:KandersCompanyIncMember2024-01-012024-03-310001860543us-gaap:OverAllotmentOptionMember2024-04-012024-04-010001860543cdre:SecondaryOfferingMember2024-03-192024-03-190001860543srt:MinimumMembercdre:RevolvingCreditFacilityDelayedDrawTermLoanA1FacilityAndDelayedDrawTermLoanA2FacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543srt:MaximumMembercdre:RevolvingCreditFacilityDelayedDrawTermLoanA1FacilityAndDelayedDrawTermLoanA2FacilityMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-200001860543cdre:AmendedAndRestatedCreditAgreementMember2024-12-2000018605432025-03-3100018605432024-12-310001860543cdre:PeriodAfterQuarterEndedMarch312026Membercdre:AmendedAndRestatedCreditAgreementMember2024-12-202024-12-200001860543cdre:EachQuarterStartingWithQuarterEndedDecember312024Membercdre:AmendedAndRestatedCreditAgreementMember2024-12-202024-12-200001860543us-gaap:RevolvingCreditFacilityMembercdre:CanadianCreditFacilityMember2021-10-140001860543cdre:TermLoanMembercdre:AmendedAndRestatedCreditAgreementMember2024-12-202024-12-200001860543cdre:AmendedAndRestatedCreditAgreementMember2024-12-202024-12-200001860543cdre:EachQuarterStartingWithQuarterEndedDecember312024Member2024-12-202024-12-200001860543us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001860543us-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-310001860543us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001860543us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001860543cdre:AlphaSafetyIntermediateLlcMember2024-02-290001860543cdre:IcorTechnologyInc.Member2024-01-090001860543cdre:IcorTechnologyInc.Member2025-01-012025-03-3100018605432024-01-012024-03-3100018605432025-01-012025-03-31iso4217:USDxbrli:purecdre:itemxbrli:sharesiso4217:CADiso4217:USDxbrli:sharescdre:segment

    Table of Contents

    ​

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 10-Q

    ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    For the quarterly period ended: March 31, 2025

    or

    ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    For the transition period from _________ to _________

    Commission File Number: 001-40698

    CADRE HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

    ​

    ​

    Delaware

        

    38-3873146

    (State or other jurisdiction of

    incorporation or organization)

    ​

    (I.R.S. Employer

    Identification Number)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    13386 International Pkwy

    Jacksonville, Florida

        

    32218

    (Address of principal executive offices)

    ​

    (Zip code)

    ​

    (904) 741-5400

    ​

    (Registrant’s telephone number, including area code)

    ​

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    ​

    ​

    ​

    ​

    ​

    Title of each class

        

    Trading Symbol

        

    Name of each exchange on which registered

    Common Stock, par value $0.0001 per share

    ​

    CDRE

    ​

    New York Stock Exchange

    ​

    Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

    Yes  ☑ No  ☐

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

    Yes  ☑ No  ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    ​

    ​

    Large accelerated filer

    ☐

        

    Non-accelerated filer

    ☐

    ​

    ​

    ​

    ​

    ​

    Accelerated filer

    ☒

    ​

    Smaller reporting company

    ☐

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Emerging growth company

    ☒

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

    As of May 2, 2025, there were 40,659,585 shares of common stock, par value $0.0001, outstanding.

    ​

    ​

    ​

    ​

    ​

    Table of Contents

    INDEX

    CADRE HOLDINGS, INC.

    PART I

    FINANCIAL INFORMATION

    Page

    Item 1.

    Financial Statements (Unaudited)

    ​

    ​

    ​

    ​

    ​

    Condensed Consolidated Balance Sheets – March 31, 2025 and December 31, 2024

    5

    ​

    Condensed Consolidated Statements of Operations and Comprehensive Income – Three months ended March 31, 2025 and 2024

    6

    ​

    Condensed Consolidated Statements of Cash Flows –Three months ended March 31, 2025 and 2024

    7

    ​

    Condensed Consolidated Statements of Shareholders’ Equity – Three months ended March 31, 2025 and 2024

    8

    ​

    Notes to Condensed Consolidated Financial Statements

    9

    Item 2.

    Management’s Discussion and Analysis of Financial Condition and Results of Operations

    26

    Item 3.

    Quantitative and Qualitative Disclosures About Market Risk

    35

    Item 4.

    Controls and Procedures

    36

    ​

    ​

    ​

    PART II

    OTHER INFORMATION

    ​

    ​

    ​

    ​

    Item 1.

    Legal Proceedings

    37

    Item 1A.

    Risk Factors

    37

    Item 5.

    Other Information

    37

    Item 6.

    Exhibits

    38

    Signature Page

    39

    ​

    ​

    ​

    2

    Table of Contents

    This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Except where the context otherwise requires or where otherwise indicated, the terms the “Company”, “Cadre”, “we,” “us,” and “our,” refer to the consolidated business of Cadre Holdings, Inc. and its consolidated subsidiaries. All statements in this Report, other than statements of historical fact, are forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, hopes, beliefs, intentions, and strategies regarding future events and are based on currently available information as to the outcome and timing of future events. In some cases, you can identify forward-looking statements because they contain words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “could,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. The Company cautions you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company, incident to its business.

    Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. These forward-looking statements are based on information available as of the date of this Report (or, in the case of forward-looking statements incorporated herein by reference, if any, as of the date of the applicable filed document), and any accompanying supplement, and current expectations, forecasts and assumptions, and involve a number of risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing the Company’s views as of any subsequent date, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. Our forward-looking statements do not reflect the potential impact of any future acquisitions, partnerships, mergers, dispositions, joint ventures, or investments we may make.

    As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:

    ●the availability of capital to satisfy our working capital requirements;
    ●anticipated trends and challenges in our business and the markets in which we operate;
    ●our ability to anticipate market needs or develop new or enhanced products to meet those needs;
    ●our expectations regarding market acceptance of our products;
    ●the success of competing products by others that are or become available in the market in which we sell our products;
    ●the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception;
    ●changes in political, economic or regulatory conditions generally and in the markets in which we operate;
    ●the impact of political unrest, natural disasters or other crises, terrorist acts, acts of war and/or military operations;
    ●our ability to maintain or broaden our business relationships and develop new relationships with strategic alliances, suppliers,
    ●customers, distributors or otherwise;
    ●our ability to retain and attract senior management and other key employees;

    3

    Table of Contents

    ●our ability to quickly and effectively respond to new technological developments;
    ●the effect of an outbreak of disease or similar public health threat, such as the COVID-19 pandemic, on the Company’s business;
    ●logistical challenges related to supply chain disruptions and delays;
    ●the impact of inflationary pressures and our ability to mitigate such impacts with pricing and productivity;
    ●the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors;
    ●the ability of our information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes;
    ●our ability to properly maintain, protect, repair or upgrade our information technology systems or information security systems, or problems with our transitioning to upgraded or replacement systems;
    ●our ability to protect our trade secrets or other proprietary rights and operate without infringing upon the proprietary rights of others and prevent others from infringing on the proprietary rights of the Company;
    ●our ability to maintain a quarterly dividend;
    ●the expenses associated with being a public company, including but not limited to expenses associated with disclosure and reporting obligations;
    ●any material differences in the actual financial results of the Company’s past and future acquisitions as compared with the Company’s expectations;
    ●our ability to integrate the operations of the businesses we have acquired or may acquire in the future;
    ●potential legal, reputational, operational and financial effects on the Company resulting from future cybersecurity incidents on the Company’s business, operations and financial results as well as the effectiveness of the Company’s response and mitigation efforts to any such cybersecurity incidents;
    ●the impact of changes in tariffs, tax laws, global trade policies as well as instability and volatility in global markets; and
    ●other risks and uncertainties set forth in the section entitled “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024, which are incorporated herein by reference.

    We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q. Other risks and uncertainties are and will be disclosed in our prior and future filings with the Securities and Exchange Commission (“SEC”) and this information should be read in conjunction with the Condensed Consolidated Financial Statements included in this Report.

    ​

    Neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements.

    ​

    ​

    ​

    4

    Table of Contents

    PART I. FINANCIAL INFORMATION

    ITEM 1. FINANCIAL STATEMENTS

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

        

    December 31, 2024

    Assets

     

    ​

      

     

    ​

      

    Current assets

     

    ​

      

     

    ​

      

    Cash and cash equivalents

    ​

    $

    133,431

    ​

    $

    124,933

    Accounts receivable, net of allowance for doubtful accounts of $858 and $876, respectively

    ​

    ​

    82,902

    ​

    ​

    93,523

    Inventories

    ​

     

    91,786

    ​

     

    82,351

    Prepaid expenses

    ​

     

    17,039

    ​

     

    19,027

    Other current assets

    ​

     

    7,357

    ​

     

    7,737

    Total current assets

    ​

     

    332,515

    ​

     

    327,571

    Property and equipment, net of accumulated depreciation and amortization of $56,244 and $54,384, respectively

    ​

     

    45,080

    ​

     

    45,243

    Operating lease assets

    ​

    ​

    15,595

    ​

    ​

    15,454

    Deferred tax assets, net

    ​

     

    4,640

    ​

     

    4,552

    Intangible assets, net

    ​

     

    105,884

    ​

     

    107,544

    Goodwill

    ​

     

    148,611

    ​

     

    148,157

    Other assets

    ​

     

    3,968

    ​

     

    4,192

    Total assets

    ​

    $

    656,293

    ​

    $

    652,713

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Liabilities, Mezzanine Equity and Shareholders' Equity

    ​

     

      

    ​

     

      

    Current liabilities

    ​

     

      

    ​

     

      

    Accounts payable

    ​

    $

    32,122

    ​

    $

    29,644

    Accrued liabilities

    ​

     

    41,604

    ​

     

    46,413

    Income tax payable

    ​

     

    8,560

    ​

     

    6,693

    Current portion of long-term debt

    ​

     

    11,380

    ​

     

    11,375

    Total current liabilities

    ​

     

    93,666

    ​

     

    94,125

    Long-term debt

    ​

     

    209,134

    ​

     

    211,830

    Long-term operating lease liabilities

    ​

    ​

    10,983

    ​

    ​

    10,733

    Deferred tax liabilities

    ​

     

    18,101

    ​

     

    18,758

    Other liabilities

    ​

     

    6,847

    ​

     

    5,752

    Total liabilities

    ​

     

    338,731

    ​

     

    341,198

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Commitments and contingencies (Note 8)

    ​

     

    ​

    ​

     

      

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Mezzanine equity

    ​

     

    ​

    ​

     

      

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and December 31, 2024)

    ​

     

    —

    ​

     

    —

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Shareholders' equity

    ​

     

    ​

    ​

     

    ​

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,659,585 and 40,607,988 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)

    ​

     

    4

    ​

     

    4

    Additional paid-in capital

    ​

     

    307,625

    ​

     

    306,821

    Accumulated other comprehensive loss

    ​

     

    (1,535)

    ​

     

    (1,389)

    Accumulated earnings

    ​

     

    11,468

    ​

     

    6,079

    Total shareholders’ equity

    ​

     

    317,562

    ​

     

    311,515

    Total liabilities, mezzanine equity and shareholders' equity

    ​

    $

    656,293

    ​

    $

    652,713

    ​

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    ​

    5

    Table of Contents

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

    COMPREHENSIVE INCOME

    (Unaudited)

    (In thousands, except share and per share amounts)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    Net sales

    ​

    $

    130,106

    ​

    $

    137,860

    Cost of goods sold

    ​

     

    73,975

    ​

     

    80,232

    Gross profit

    ​

     

    56,131

    ​

     

    57,628

    Operating expenses

    ​

     

      

    ​

     

      

    Selling, general and administrative

    ​

     

    41,753

    ​

     

    40,719

    Restructuring and transaction costs

    ​

     

    698

    ​

     

    3,087

    Related party expense

    ​

     

    128

    ​

     

    1,843

    Total operating expenses

    ​

     

    42,579

    ​

     

    45,649

    Operating income

    ​

     

    13,552

    ​

     

    11,979

    Other expense

    ​

     

      

    ​

     

      

    Interest expense

    ​

     

    (2,231)

    ​

     

    (1,637)

    Other income (expense), net

    ​

     

    1,287

    ​

     

    (1,444)

    Total other expense, net

    ​

     

    (944)

    ​

     

    (3,081)

    Income before provision for income taxes

    ​

     

    12,608

    ​

     

    8,898

    Provision for income taxes

    ​

     

    (3,360)

    ​

     

    (1,970)

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Net income per share:

    ​

     

      

    ​

     

      

    Basic

    ​

    $

    0.23

    ​

    $

    0.18

    Diluted

    ​

    $

    0.23

    ​

    $

    0.18

    Weighted average shares outstanding:

    ​

     

      

    ​

     

      

    Basic

    ​

     

    40,618,554

    ​

     

    37,946,576

    Diluted

    ​

     

    40,980,861

    ​

     

    38,554,185

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    Other comprehensive income:

    ​

     

      

    ​

     

      

    Unrealized holding (losses) gains on derivative instruments, net of tax(1)

    ​

    ​

    (750)

    ​

    ​

    1,660

    Reclassification adjustments for gains included in net income, net of tax(2)

    ​

    ​

    (263)

    ​

    ​

    (894)

    Total unrealized (loss) gain on derivative instruments, net of tax

    ​

    ​

    (1,013)

    ​

    ​

    766

    Foreign currency translation adjustments, net of tax(3)

    ​

     

    867

    ​

     

    (412)

    Other comprehensive (loss) income

    ​

    ​

    (146)

    ​

    ​

    354

    Comprehensive income, net of tax

    ​

    $

    9,102

    ​

    $

    7,282

    (1) Net of income tax of $250 and $546 for the three months ended March 31, 2025 and 2024, respectively.

    (2) Amounts reclassified to net income relate to gains on interest rate swaps and foreign currency hedges and are included in Interest expense above. Amounts are net of income tax of $190 and $284 for the three months ended March 31, 2025 and 2024, respectively.

    (3) Net of income tax of $119 and $99 for the three months ended March 31, 2025 and 2024, respectively.

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    6

    Table of Contents

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    Cash Flows From Operating Activities:

     

    ​

      

     

    ​

      

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    Adjustments to reconcile net income to net cash provided by operating activities:

    ​

     

      

    ​

     

      

    Depreciation and amortization

    ​

     

    3,856

    ​

     

    3,942

    Amortization of original issue discount and debt issue costs

    ​

     

    500

    ​

     

    149

    Amortization of inventory step-up

    ​

    ​

    —

    ​

    ​

    769

    Deferred income taxes

    ​

     

    533

    ​

     

    1,546

    Stock-based compensation

    ​

    ​

    1,968

    ​

    ​

    2,067

    Remeasurement of contingent consideration

    ​

    ​

    331

    ​

    ​

    451

    (Recoveries from) provision for losses on accounts receivable

    ​

     

    (17)

    ​

     

    480

    Unrealized foreign exchange transaction (gain) loss

    ​

     

    (731)

    ​

     

    934

    Other loss (gain)

    ​

    ​

    41

    ​

    ​

    52

    Changes in operating assets and liabilities, net of impact of acquisitions:

    ​

     

    ​

    ​

     

    ​

    Accounts receivable

    ​

     

    10,633

    ​

     

    2,696

    Inventories

    ​

     

    (9,143)

    ​

     

    1,818

    Prepaid expenses and other assets

    ​

     

    1,340

    ​

     

    2,028

    Accounts payable and other liabilities

    ​

     

    (1,168)

    ​

     

    (21,723)

    Net cash provided by operating activities

    ​

     

    17,391

    ​

     

    2,137

    Cash Flows From Investing Activities:

    ​

     

      

    ​

     

      

    Purchase of property and equipment

    ​

     

    (1,309)

    ​

     

    (1,343)

    Business acquisitions, net of cash acquired

    ​

     

    —

    ​

     

    (141,293)

    Net cash used in investing activities

    ​

     

    (1,309)

    ​

     

    (142,636)

    Cash Flows From Financing Activities:

    ​

     

      

    ​

     

      

    Proceeds from revolving credit facilities

    ​

     

    —

    ​

     

    5,500

    Principal payments on revolving credit facilities

    ​

     

    —

    ​

     

    (5,500)

    Proceeds from term loans

    ​

    ​

    —

    ​

    ​

    80,000

    Principal payments on term loans

    ​

     

    (2,813)

    ​

     

    (2,500)

    Principal payments on insurance premium financing

    ​

     

    —

    ​

     

    (1,083)

    Payments for debt issuance costs

    ​

    ​

    —

    ​

    ​

    (844)

    Taxes paid in connection with employee stock transactions

    ​

    ​

    (1,140)

    ​

    ​

    (5,311)

    Proceeds from secondary offering, net of underwriter discounts

    ​

    ​

    —

    ​

    ​

    73,535

    Deferred offering costs

    ​

    ​

    —

    ​

    ​

    (722)

    Dividends distributed

    ​

     

    (3,859)

    ​

     

    (3,289)

    Net cash (used in) provided by financing activities

    ​

     

    (7,812)

    ​

     

    139,786

    Effect of foreign exchange rates on cash and cash equivalents

    ​

     

    228

    ​

     

    74

    Change in cash and cash equivalents

    ​

     

    8,498

    ​

     

    (639)

    Cash and cash equivalents, beginning of period

    ​

     

    124,933

    ​

     

    87,691

    Cash and cash equivalents, end of period

    ​

    $

    133,431

    ​

    $

    87,052

    Supplemental Disclosure of Cash Flows Information:

    ​

    ​

    ​

    ​

    ​

    ​

    Cash paid for income taxes, net

    ​

    $

    2,017

    ​

    $

    9,369

    Cash paid for interest

    ​

    $

    3,527

    ​

    $

    2,498

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

    ​

    ​

    ​

    ​

    ​

    ​

    Accruals and accounts payable for capital expenditures

    ​

    $

    104

    ​

    $

    210

    Accruals for taxes paid in connection with employee stock transactions

    ​

    $

    24

    ​

    $

    —

    ​

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    ​

    7

    Table of Contents

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

    (Unaudited)

    (In thousands, except per share amounts)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Additional 

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Common Stock

    ​

    Paid-In 

    ​

    Accumulated Other 

    ​

    Accumulated 

    ​

    Shareholders' 

    ​

        

    Shares

        

    Amount

        

    Capital

        

    Comprehensive Loss

        

    Earnings

        

    Equity

    Balance, December 31, 2024

     

    40,607,988

     

    $

    4

     

    $

    306,821

     

    $

    (1,389)

     

    $

    6,079

     

    $

    311,515

    Net income

     

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    9,248

    ​

    ​

    9,248

    Dividends declared ($0.095 per share)

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (3,859)

    ​

    ​

    (3,859)

    Stock-based compensation

    ​

    —

    ​

    ​

    —

    ​

    ​

    1,968

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    1,968

    Common stock issued under employee compensation plans

    ​

    86,006

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    Common stock withheld related to net share settlement of stock-based compensation

    ​

    (34,409)

    ​

    ​

    —

    ​

    ​

    (1,164)

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (1,164)

    Foreign currency translation adjustments

     

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    867

    ​

    ​

    —

    ​

    ​

    867

    Change in fair value of derivative instruments

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (1,013)

    ​

    ​

    —

    ​

    ​

    (1,013)

    Balance, March 31, 2025

     

    40,659,585

    ​

    $

    4

    ​

    $

    307,625

    ​

    $

    (1,535)

    ​

    $

    11,468

    ​

    $

    317,562

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Additional 

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Common Stock

    ​

    Paid-In 

    ​

    Accumulated Other 

    ​

    Accumulated 

    ​

    Shareholders' 

    ​

        

    Shares

        

    Amount

        

    Capital

        

    Comprehensive Income

        

    Deficit

        

    Equity

    Balance, December 31, 2023

     

    37,587,436

     

    $

    4

     

    $

    212,630

     

    $

    634

     

    $

    (16,106)

    ​

    $

    197,162

    Net income

     

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    6,928

    ​

     

    6,928

    Dividends declared ($0.0875 per share)

     

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (3,289)

    ​

     

    (3,289)

    Issuance of common stock in secondary offering, net of underwriter discounts and issuance costs

    ​

    2,200,000

    ​

    ​

    —

    ​

    ​

    72,813

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    72,813

    Stock-based compensation

    ​

    —

    ​

    ​

    —

    ​

    ​

    2,044

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    2,044

    Common stock issued under employee compensation plans

    ​

    423,688

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    Common stock withheld related to net share settlement of stock-based compensation

    ​

    (150,680)

    ​

    ​

    —

    ​

    ​

    (5,311)

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (5,311)

    Foreign currency translation adjustments

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    (412)

    ​

    ​

    —

    ​

    ​

    (412)

    Change in fair value of derivative instruments

    ​

    —

    ​

    ​

    —

    ​

    ​

    —

    ​

    ​

    766

    ​

    ​

    —

    ​

    ​

    766

    Balance, March 31, 2024

     

    40,060,444

    ​

    $

    4

    ​

    $

    282,176

    ​

    $

    988

    ​

    $

    (12,467)

    ​

    $

    270,701

    ​

    The accompanying notes are an integral part of these condensed consolidated financial statements.

    ​

    ​

    ​

    8

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    (Unaudited)

    (in thousands, except share and per share amounts)

    1.    SIGNIFICANT ACCOUNTING POLICIES

    Nature of Operations and Basis of Presentation

    Cadre Holdings, Inc., D/B/A The Safariland Group (the “Company”, “Cadre”, “we”, “us”, and “our”), a Delaware corporation, began operations on April 12, 2012. The Company, headquartered in Jacksonville, Florida, is a global leader in manufacturing and distributing safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. The business operates through 20 manufacturing plants within the U.S., Mexico, Canada, the United Kingdom, Italy, France, and Lithuania, and sells its products worldwide through its direct sales force, distribution channel and distribution partners, online stores, and third-party resellers.

    Principles of Consolidation

    The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP" or “U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of the Company, its wholly owned subsidiaries, and other entities consolidated as required by GAAP. Accordingly, they do not include all of the information and footnotes required by GAAP for annual audited financial statements. The unaudited condensed consolidated interim financial statements have been prepared on a basis consistent with the audited consolidated financial statements and include all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. These condensed consolidated interim financial statements and notes thereto should be read in conjunction with the Company’s most recently completed annual consolidated financial statements. All adjustments considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation.

    Secondary Offering

    On March 19, 2024, the Company completed a secondary offering in which the Company issued and sold 2,200,000 shares of common stock at a price of $35.00 per share. The Company’s net proceeds from the sale of shares were $72,813 after underwriter discounts and commissions, fees and expenses of $4,187.

    On April 1, 2024, the underwriters exercised the full amount of their over-allotment option and purchased an additional 545,719 shares of common stock at a price of $35.00 per share, resulting in net proceeds to the Company of $18,280 after underwriter discounts and commissions, fees and expenses of $820.

    Emerging Growth Company

    We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation or golden parachute arrangements.

    In addition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our condensed consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates.

    ​

    9

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    Use of Estimates

    The preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

    Fair Value Measurements

    The Company follows the guidance of Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. This guidance also establishes the following three-level hierarchy based upon the transparency of inputs to the valuation of an asset or liability on the measurement date:

    Level 1: Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets.

    Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

    Level 3: Unobservable inputs that reflect assumptions about what market participants would use in pricing assets or liabilities based on the best information available.

    The Company’s financial instruments consist principally of cash and cash equivalents (money market funds), accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities, income tax payable and debt. The carrying amounts of certain of these financial instruments, including cash and cash equivalents (money market funds), accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities and income tax payable approximate their current fair value due to the relatively short-term nature of these accounts.

    The following table presents our fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

    ​

    December 31, 2024

    ​

    ​

    Carrying 

    ​

    Fair Value

    ​

    Carrying 

    ​

    Fair Value

    ​

        

    Amount

        

    ​

    Level 1

        

    ​

    Level 2

        

    ​

    Level 3

        

    Amount

        

    ​

    Level 1

        

    ​

    Level 2

        

    ​

    Level 3

    Assets:

     

    ​

      

     

    ​

      

     

    ​

      

     

    ​

      

     

    ​

      

     

    ​

      

     

    ​

      

     

    ​

      

    Money market funds

    ​

    $

    26,370

    ​

    $

    26,370

    ​

    $

    —

    ​

    $

    —

    ​

    $

    110,671

    ​

    $

    110,671

    ​

    $

    —

    ​

    $

    —

    Derivative instruments (Note 7)

    ​

    $

    3,095

    ​

    $

    —

    ​

    $

    3,095

    ​

    $

    —

    ​

    $

    4,465

    ​

    $

    —

    ​

    $

    4,465

    ​

    $

    —

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Liabilities:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Derivative instruments (Note 7)

    ​

    $

    843

    ​

    $

    —

    ​

    $

    843

    ​

    $

    —

    ​

    $

    —

    ​

    $

    —

    ​

    $

    —

    ​

    $

    —

    Contingent consideration (Note 2)

    ​

    $

    3,559

    ​

    $

    —

    ​

    $

    —

    ​

    $

    3,559

    ​

    $

    3,211

    ​

    $

    —

    ​

    $

    —

    ​

    $

    3,211

    ​

    There were no transfers of assets or liabilities between levels during the three months ended March 31, 2025 and 2024.

    There have not been material changes in the fair value of debt (Level 2), as compared to the carrying value, as of March 31, 2025 and December 31, 2024.

    Revenue Recognition

    The Company derives revenue primarily from the sale of physical products. The Company recognizes such revenue at point-in-time when a contract exists with a customer that specifies the goods and services to be provided at an agreed upon sales price and when the

    10

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    performance obligation is satisfied by transferring the goods or service to the customer. The performance obligation is considered satisfied when control transfers, which is generally determined when products are shipped or delivered to the customer but could be delayed until the receipt of customer acceptance, depending on the terms of the contract. Sales are made on normal and customary short-term credit terms or upon delivery for point of sale transactions.

    The Company enters into contractual arrangements primarily with customers in the form of individual customer orders which specify the goods, quantity, pricing, and associated order terms.

    The Company has certain long-term contracts that contain performance obligations that are satisfied over time. The Company invoices the customer once the billing milestone is reached and collects under customary short-term credit terms. For long-term contracts, the Company recognizes revenue using the input method based on costs incurred, as this method is an appropriate measure of progress toward the complete satisfaction of the performance obligation. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near-term. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made. When the current estimate of total costs for a performance obligation indicates a loss, a provision for the entire estimated loss on the unsatisfied performance obligation is made in the period in which the loss becomes evident.

    At the time of revenue recognition, the Company also provides for estimated sales returns and miscellaneous claims from customers as reductions to revenues. The estimates are based on historical rates of product returns and claims. The Company accrues for such estimated returns and claims with an estimated accrual and associated reduction of revenue. Additionally, the Company records inventory that it expects to be returned as part of inventories, with a corresponding reduction to cost of goods sold.

    Charges for shipping and handling fees billed to customers are included in net sales and the corresponding shipping and handling expenses are included in cost of goods sold in the accompanying condensed consolidated statements of operations and comprehensive income. We consider our costs related to shipping and handling after control over a product has transferred to a customer to be a cost of fulfilling the promise to transfer the product to the customer.

    Sales commissions paid to employees as compensation are expensed as incurred for contracts with service periods less than a year. For contracts with service periods greater than a year, these costs have historically been immaterial and are capitalized and amortized over the life of the contract. Commission costs are recorded in selling, general and administrative expenses in the Company’s condensed consolidated statements of operations and comprehensive income.

    Product Warranty

    Some of the Company’s manufactured products carry limited warranty provisions for defects in quality and workmanship. A warranty reserve is established at the time of sale to cover estimated costs based on the Company’s history of warranty repairs and replacements, and is recorded in cost of goods sold in the Company’s condensed consolidated statements of operations and comprehensive income.

    The following table sets forth the changes in the Company’s accrued warranties, which are recorded in accrued liabilities in the condensed consolidated balance sheets:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    Beginning accrued warranty expense

    ​

    $

    1,760

    ​

    $

    1,610

    Current period claims

    ​

     

    (74)

    ​

     

    (116)

    Provision for current period sales

    ​

     

    8

    ​

     

    57

    Ending accrued warranty expense

    ​

    $

    1,694

    ​

    $

    1,551

    ​

    11

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    Net Income per Share

    Basic income per share is computed by dividing net income by the weighted average number of common shares outstanding during the periods presented. Diluted income per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of potential common shares, determined using the treasury-stock method. The calculation of weighted average shares outstanding and net income per share are as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three months ended March 31, 

    ​

        

    2025

        

    2024

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    ​

    ​

     

      

    ​

     

      

    Weighted average shares outstanding - basic

    ​

     

    40,618,554

    ​

     

    37,946,576

    Effect of dilutive securities:

    ​

    ​

    ​

    ​

    ​

    ​

    Stock-based awards

    ​

    ​

    362,307

    ​

    ​

    607,609

    Weighted average shares outstanding - diluted

    ​

     

    40,980,861

    ​

     

    38,554,185

    Net income per share:

    ​

     

      

    ​

     

      

    Basic

    ​

    $

    0.23

    ​

    $

    0.18

    Diluted

    ​

    $

    0.23

    ​

    $

    0.18

    ​

    For the three months ended March 31, 2025 and 2024, equity awards of 776,215 and 328,474, respectively, were outstanding and anti-dilutive and therefore not included in the calculation of net income per share for these periods.

    Recent Accounting Pronouncements

    Accounting Pronouncements Not Yet Adopted

    In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires a public entity to disclose in its rate reconciliation table additional categories of information about federal, state and foreign income taxes and provide more details about the reconciling items in some categories if items meet a quantitative threshold. The guidance will require all entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. All entities are required to apply the guidance prospectively, with the option to apply it retrospectively. The guidance is effective for public business entities for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the enhanced disclosure requirements, however, we do not anticipate a material change to our financial position, results of operations or cash flows.

    ​

    12

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    2.    ACQUISITIONS

    ICOR Acquisition

    On January 9, 2024, Med-Eng, ULC, a wholly-owned subsidiary of the Company, completed the acquisition of ICOR Technology Inc. (“ICOR”), a trusted global supplier of high-quality, reliable, innovative, and cost-effective explosive ordnance disposal robots.

    Total consideration, net of cash acquired, was $39,282 for 100% of the equity interests in ICOR. The total consideration was as follows:

    ​

    ​

    ​

    ​

    ​

    Cash paid

        

    $

    40,350

    Less: cash acquired

    ​

    ​

    (1,068)

    Plus: Contingent consideration

    ​

    ​

    2,226

    Total consideration, net

    ​

    $

    41,508

    ​

    The following table summarizes the final purchase price consideration and the amounts recognized for the assets acquired and liabilities assumed, which have been estimated at their fair values. The excess of purchase consideration over the assets acquired and liabilities assumed is recorded as goodwill. Goodwill for the ICOR acquisition is included in the Product segment and reflects synergies and additional legacy growth and profitability expected from this acquisition through expansion into new markets and customers.

    ​

    ​

    ​

    ​

    ​

    Total consideration, net

        

    $

    41,508

    ​

    ​

    ​

    ​

    Accounts receivable

    ​

    $

    2,352

    Inventories

    ​

    ​

    8,086

    Prepaid expenses and other current assets

    ​

    ​

    612

    Property and equipment

    ​

    ​

    239

    Operating lease assets

    ​

    ​

    1,369

    Intangible assets

    ​

    ​

    17,200

    Goodwill

    ​

    ​

    18,602

    Total assets acquired

    ​

    ​

    48,460

    Accounts payable

    ​

    ​

    635

    Accrued liabilities

    ​

    ​

    1,455

    Long-term operating lease liabilities

    ​

    ​

    967

    Deferred tax liabilities

    ​

    ​

    3,895

    Total liabilities assumed

    ​

    ​

    6,952

    Net assets acquired

    ​

    $

    41,508

    ​

    ​

    13

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    In connection with the acquisition, the Company acquired exclusive rights to ICOR’s trademarks, customer relationships, and product technologies. The amounts assigned to each class of intangible asset and the related average useful lives are as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Gross

        

    Average Useful Life

    Customer relationships

    ​

    $

    1,496

    ​

    ​

    10

    Technology

    ​

    ​

    14,283

    ​

     

    10

    Trademarks

    ​

    ​

    1,421

    ​

    ​

    10

    Total

    ​

    $

    17,200

    ​

    ​

    ​

    ​

    The full amount of goodwill of $18,602 is expected to be non-deductible for tax purposes.

    As part of the ICOR acquisition, the purchase agreement with respect to the acquisition provided for the payment of contingent consideration of up to CDN$8,000 (approximately $5,797) based upon future cumulative net sales during the three-year period ended January 9, 2027. Using a Monte-Carlo pricing model, the Company estimated the fair value of the contingent consideration to be $2,225 as of January 9, 2024. Significant unobservable inputs used in the valuation include a discount rate of 6.2% and the probability adjusted net sales during the contingency period. The contingent consideration liability is remeasured at the estimated fair value at the end of each reporting period with the change in fair value recognized within operating income in the condensed consolidated statements of operations and comprehensive income for such period. We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements.

    As the contingent consideration liability is remeasured to fair value each reporting period, significant increases or decreases in projected sales, discount rates or the time until payment is made could result in a significantly lower or higher fair value measurement. Our determination of fair value of the contingent consideration liabilities could change in future periods based on our ongoing evaluation of these significant unobservable inputs.

    The following table summarizes the changes in the contingent consideration liability for the three months ended March 31, 2025:

    ​

    ​

    ​

    ​

    ​

    Balance, December 31, 2024

    ​

    $

    3,211

    Fair value adjustment

    ​

    ​

    331

    Foreign currency translation adjustments

    ​

     

    17

    Balance, March 31, 2025

    ​

    $

    3,559

    ​

    Alpha Safety Acquisition

    On February 29, 2024, Safariland, LLC, a wholly-owned subsidiary of the Company, completed the acquisition of Alpha Safety Intermediate, LLC (“Alpha Safety”), a provider of highly engineered technical products and services spanning the nuclear value chain.

    Total consideration, net of cash acquired, was $102,531 for 100% of the equity interests in Alpha Safety. The total consideration was as follows:

    ​

    ​

    ​

    ​

    ​

    Cash paid

        

    $

    107,138

    Less: cash acquired

    ​

     

    (4,607)

    Total consideration, net

    ​

    $

    102,531

    ​

    14

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    The following table summarizes the final purchase price consideration and the amounts recognized for the assets acquired and liabilities assumed, which have been estimated at their fair values. The excess of purchase consideration over the assets acquired and liabilities assumed is recorded as goodwill. Goodwill for the Alpha Safety acquisition is included in the Product segment and reflects synergies and additional legacy growth and profitability expected from this acquisition through expansion into new markets and customers.

    ​

    ​

    ​

    ​

    ​

    Total consideration, net

        

    $

    102,531

    ​

    ​

    ​

    ​

    Accounts receivable

    ​

    $

    9,189

    Inventories

    ​

    ​

    8,527

    Prepaid expenses and other current assets

    ​

    ​

    1,889

    Property and equipment

    ​

    ​

    2,189

    Operating lease assets

    ​

    ​

    2,262

    Intangible assets

    ​

    ​

    57,800

    Goodwill

    ​

    ​

    49,133

    Total assets acquired

    ​

    ​

    130,989

    Accounts payable

    ​

    ​

    1,896

    Accrued liabilities

    ​

    ​

    12,570

    Long-term operating lease liabilities

    ​

    ​

    1,573

    Deferred tax liabilities

    ​

    ​

    12,419

    Total liabilities assumed

    ​

    ​

    28,458

    Net assets acquired

    ​

    $

    102,531

    ​

    In connection with the acquisition, the Company acquired exclusive rights to Alpha Safety’s trademarks, customer relationships, and product technologies. The amounts assigned to each class of intangible asset and the related average useful lives are as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Gross

        

    Average Useful Life

    Customer relationships

    ​

    $

    17,900

    ​

    ​

    20

    Technology

    ​

    ​

    35,200

    ​

     

    15

    Trademarks

    ​

    ​

    4,700

    ​

    ​

    10

    Total

    ​

    $

    57,800

    ​

    ​

    ​

    ​

    The full amount of goodwill of $49,133 is expected to be non-deductible for tax purposes.

    15

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    3.    REVENUE RECOGNITION

    The following tables disaggregate net sales by channel and geography:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    U.S. state and local agencies (a)

    ​

    $

    73,409

    ​

    $

    74,992

    Commercial

    ​

     

    11,019

    ​

     

    11,265

    U.S. federal agencies

    ​

     

    21,484

    ​

     

    21,186

    International

    ​

     

    22,881

    ​

     

    29,437

    Other

    ​

     

    1,313

    ​

     

    980

    Net sales

    ​

    $

    130,106

    ​

    $

    137,860

    ​

    (a) Includes all Distribution sales

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    United States

    ​

    $

    107,225

    ​

    $

    108,423

    International

    ​

     

    22,881

    ​

     

    29,437

    Net sales

    ​

    $

    130,106

    ​

    $

    137,860

    ​

    Revenue by product is not disclosed, as it is impractical to do so.

    Contract Assets and Liabilities

    Contract assets represent unbilled amounts resulting from certain long-term contracts that contain performance obligations that are satisfied over time. In these contracts, the revenue recognized exceeds the amount billed to the customer. Contract assets are included in accounts receivable, net in the Company’s condensed consolidated balance sheets and totaled $15,300 and $9,550 as of March 31, 2025 and December 31, 2024, respectively.

    Contract liabilities are recorded as a component of other liabilities when customers are billed or remit cash payments in advance of the Company satisfying performance obligations. Contract liabilities are recognized into revenue when the performance obligation is satisfied. Contract liabilities are included in accrued liabilities in the Company’s condensed consolidated balance sheets and totaled $5,924 and $7,470 as of March 31, 2025 and December 31, 2024, respectively. Revenue recognized during the three months ended March 31, 2025 from amounts included in contract liabilities as of December 31, 2024 was $2,107.

    Remaining Performance Obligations

    As of March 31, 2025, we had $42,481 of remaining unfulfilled performance obligations, which include amounts that will be invoiced and recognized in future periods. The remaining performance obligations are limited only to arrangements that meet the definition of a contract under ASC Topic 606, Revenue from Contracts with Customers, as of March 31, 2025. We expect to recognize approximately 64% of this balance over the next twelve months and expect the remainder to be recognized in the following two years.

    ​

    16

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    4.    INVENTORIES

    The following table sets forth a summary of inventories, stated at lower of cost or net realizable value, as of March 31, 2025 and December 31, 2024:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

    ​

    December 31, 2024

    Finished goods

    ​

    $

    36,395

    ​

    $

    31,209

    Work-in-process

    ​

     

    9,904

    ​

     

    8,321

    Raw materials and supplies

    ​

     

    45,487

    ​

     

    42,821

    Total

    ​

    $

    91,786

    ​

    $

    82,351

    ​

    ​

    5.    GOODWILL AND OTHER INTANGIBLE ASSETS

    Goodwill

    The following table summarizes the changes in goodwill for the three months ended March 31, 2025:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Product

        

    Distribution

        

    Total

    Balance, December 31, 2024

    ​

    $

    145,541

    ​

    $

    2,616

    ​

    $

    148,157

    Foreign currency translation adjustments

    ​

     

    454

    ​

     

    —

    ​

     

    454

    Balance, March 31, 2025

    ​

    $

    145,995

    ​

    $

    2,616

    ​

    $

    148,611

    ​

    Gross goodwill and accumulated impairment losses were $156,196 and $7,585, respectively, as of March 31, 2025 and $155,742 and $7,585, respectively, as of December 31, 2024.

    Intangible Assets

    Intangible assets such as certain customer relationships and patents on core technologies and product technologies are amortizable over their estimated useful lives. Certain trade names and trademarks which provide exclusive and perpetual rights to manufacture and sell their respective products are deemed indefinite-lived and are therefore not subject to amortization.

    Intangible assets consisted of the following as of March 31, 2025 and December 31, 2024:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

    ​

        

    ​

    ​

        

    ​

    ​

        

    ​

    ​

        

    Weighted 

    ​

    ​

    ​

    ​

    ​

    ​

    Accumulated 

    ​

    ​

    ​

    ​

    Average 

    ​

    ​

    Gross

    ​

    ​

    Amortization

    ​

    ​

    Net

     

    Useful Life

    Definite-lived intangibles:

     

    ​

      

     

    ​

      

     

    ​

      

     

      

    Customer relationships

    ​

    $

    105,602

     

    $

    (70,183)

     

    $

    35,419

     

    17

    Technology

    ​

     

    64,744

     

     

    (16,956)

     

     

    47,788

     

    13

    Tradenames

    ​

     

    12,683

     

     

    (7,177)

     

     

    5,506

     

    9

    Non-compete agreements

    ​

     

    1,012

     

     

    (1,012)

     

     

    —

     

    -

    ​

    ​

    $

    184,041

     

    $

    (95,328)

     

    $

    88,713

    ​

    ​

    Indefinite-lived intangibles:

    ​

     

      

     

     

      

     

     

      

     

      

    Tradenames

    ​

     

    17,171

     

     

    —

     

     

    17,171

     

    Indefinite

    Total

    ​

    $

    201,212

     

    $

    (95,328)

     

    $

    105,884

     

      

    ​

    17

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    December 31, 2024

    ​

        

    ​

    ​

        

    ​

    ​

        

    ​

    ​

        

    Weighted 

    ​

    ​

    ​

    ​

    ​

    ​

    Accumulated 

    ​

    ​

    ​

    ​

    Average 

    ​

    ​

    Gross

    ​

    ​

    Amortization

    ​

    ​

    Net

     

    Useful Life

    Definite-lived intangibles:

     

    ​

      

     

    ​

      

     

    ​

      

     

      

    Customer relationships

    ​

    $

    105,060

     

    $

    (69,118)

     

    $

    35,942

     

    17

    Technology

    ​

     

    64,600

     

     

    (15,819)

     

     

    48,781

     

    13

    Tradenames

    ​

     

    12,596

     

     

    (6,941)

     

     

    5,655

     

    9

    Non-compete agreements

    ​

     

    996

     

     

    (996)

     

     

    —

     

    -

    ​

    ​

    $

    183,252

     

    $

    (92,874)

     

    $

    90,378

    ​

    ​

    Indefinite-lived intangibles:

    ​

     

      

     

     

      

     

     

      

     

      

    Tradenames

    ​

     

    17,166

     

     

    —

     

     

    17,166

     

    Indefinite

    Total

    ​

    $

    200,418

     

    $

    (92,874)

     

    $

    107,544

     

      

    ​

    ​

    Amortization expense for the three months ended March 31, 2025 and 2024 was $2,095 and $2,215, respectively, of which $1,074 and $690 was included in cost of goods sold in the condensed consolidated statements of operations and comprehensive income for the respective periods.

    The estimated amortization expense for definite-lived intangible assets for the remaining nine months of 2025, the next four years and thereafter is as follows:

    ​

    ​

    ​

    ​

    ​

    Remainder of 2025

        

    $

    6,329

    2026

    ​

     

    8,150

    2027

    ​

     

    7,977

    2028

    ​

     

    7,977

    2029

    ​

     

    7,880

    Thereafter

    ​

     

    50,400

    Total

    ​

    $

    88,713

    ​

    ​

    6.    DEBT

    The Company’s debt is as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

    ​

    December 31, 2024

    Short-term debt:

     

    ​

      

     

    ​

      

    Current portion of term loan

    ​

    $

    11,250

    ​

    $

    11,250

    Current portion of other

    ​

     

    130

    ​

     

    125

    ​

    ​

    $

    11,380

    ​

    $

    11,375

    Long-term debt:

    ​

     

      

    ​

     

      

    Revolver

    ​

     

    —

    ​

     

    —

    Term loan

    ​

     

    210,938

    ​

     

    213,750

    Other

    ​

     

    259

    ​

     

    251

    ​

    ​

    $

    211,197

    ​

    $

    214,001

    Unamortized debt discount and debt issuance costs

    ​

     

    (2,063)

    ​

     

    (2,171)

    Total long-term debt, net

    ​

    $

    209,134

    ​

    $

    211,830

    ​

    18

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    The following summarizes the aggregate principal payments of our long-term debt, excluding debt discount and debt issuance costs, for the remaining nine months of 2025, the next four years and thereafter:

    ​

    ​

    ​

    ​

    ​

    Remainder of 2025

        

    $

    8,567

    2026

    ​

     

    11,380

    2027

    ​

     

    11,380

    2028

    ​

     

    11,250

    2029

    ​

     

    180,000

    Total principal payments

    ​

    $

    222,577

    ​

    2024 Credit Agreement

    On December 20, 2024 (the “2024 Credit Agreement Closing Date”), the Company refinanced its existing credit facilities and entered into an Amended and Restated Credit Agreement (the “2024 Credit Agreement”), whereby Safariland, LLC, as borrower (the “2024 Borrower”), the Company, and certain domestic subsidiaries of the 2024 Borrower, as guarantors (the “2024 Guarantors”), closed on and received funding under the 2024 Credit Agreement with PNC, as administrative agent, swingline lender, and issuing lender, along with several other lenders (collectively, the “2024 Lenders”). The 2024 Credit Agreement amends and restates the prior credit agreement in its entirety.

    Pursuant to the 2024 Credit Agreement, the 2024 Borrower (i) borrowed $225,000 under a term loan facility (the “2024 Term Loans”), (ii) may borrow up to $175,000 under a revolving credit facility (the “2024 Revolving Loan”), including up to $30,000 for letters of credit and up to $10,000 for swingline loans, (iii) may borrow up to $115,000 under a delayed draw term loan A-1 facility (the “DDTL A-1 Facility”) available through June 20, 2025, and (iv) may borrow up to $75,000 under a delayed draw term loan A-2 facility (the “DDTL A-2 Facility”) available through June 20, 2026. Each of these facilities matures on December 20, 2029. The proceeds of the 2024 Term Loans were used to refinance the outstanding term loans under the 2021 Credit Agreement and to pay fees and expenses incurred in connection with entering into the 2024 Credit Agreement. The 2024 Credit Agreement also permits the 2024 Borrower, subject to certain requirements, to arrange with lenders for an aggregate of $100,000 (or more if certain leverage ratios are met) of additional revolving and/or term loan commitments (both of which are currently uncommitted).

    The 2024 Borrower may elect to have borrowings under the 2024 Credit Agreement bear interest at either (i) a base rate plus an applicable margin ranging from 0.50% to 1.50% per annum or (ii) a term SOFR rate plus an applicable margin ranging from 1.50% to 2.50% per annum, in each case based on the Company’s consolidated total net leverage ratio. The 2024 Borrower is also required to pay a commitment fee on the unused portion of the 2024 Revolving Loan, the DDTL A-1 Facility, and the DDTL A-2 Facility, ranging from 0.175% to 0.25% per annum, based on the Company’s consolidated total net leverage ratio.

    The 2024 Term Loans require scheduled quarterly principal payments of 1.25% of the original aggregate principal amount, beginning March 31, 2025, with the balance due at maturity.

    The 2024 Credit Agreement is guaranteed, jointly and severally, by the 2024 Guarantors and, subject to certain exceptions, secured by a first-priority security interest in substantially all of the assets of the 2024 Borrower and the 2024 Guarantors pursuant to an Amended and Restated Security and Pledge Agreement and an Amended and Restated Guaranty and Suretyship Agreement, each dated as of the 2024 Credit Agreement Closing Date.

    19

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    The 2024 Credit Agreement contains customary representations and warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the 2024 Borrower or any 2024 Guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, dispositions, and mandatory prepayments in connection with certain liquidity events. Additionally, the 2024 Credit Agreement contains certain restrictive debt covenants, which require us to: (i) maintain a minimum fixed charge coverage ratio of 1.25 to 1.00, starting with the quarter ended December 31, 2024, which is to be determined for each quarter end on a trailing four quarter basis and (ii) maintain a quarterly maximum consolidated total net leverage ratio of 4.00 to 1.00 from the quarter ended December 31, 2024 until the quarter ended March 31, 2026, and thereafter 3.50 to 1.00, which is in each case to be determined on a trailing four quarter basis; provided that under certain circumstances and subject to certain limitations, in the event of a material acquisition, we may temporarily increase the consolidated total net leverage ratio by up to 0.50 to 1.00 for four fiscal quarters following such acquisition, subject to a maximum consolidated total net leverage ratio of 4.00 to 1.00. Furthermore, the 2024 Credit Agreement also includes customary events of default, including non-payment of principal, interest, or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payments on other material indebtedness, bankruptcy and insolvency events, material judgments, and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the 2024 Credit Agreement may be accelerated, and the Lenders could foreclose on their security interests in the assets of the Borrower and the Guarantors.

    There were no amounts outstanding under the 2024 Revolving Loan as of March 31, 2025 and December 31, 2024. As of March 31, 2025, there were $2,165 in outstanding letters of credit and $172,835 of availability.

    Canadian Credit Facility

    On October 14, 2021, Med-Eng Holdings ULC and Pacific Safety Products Inc., the Company’s Canadian subsidiaries, as borrowers (the “Canadian Borrowers”), and Safariland, LLC, as guarantor (the “Canadian Guarantor”), closed on a line of credit pursuant to a Loan Agreement (the “Canadian Loan Agreement”) and a Revolving Line of Credit Note (the “Note”) with PNC Bank Canada Branch (“PNC Canada”), as lender pursuant to which the Canadian Borrowers may borrow up to CDN$10,000 under a revolving line of credit (including up to $3,000 for letters of credit) (the “Revolving Canadian Loan”). The Revolving Canadian Loan matures on July 23, 2026. The Canadian Loan Agreement is guaranteed by the Canadian Guarantor pursuant to a Guaranty and Suretyship Agreement (the “Canadian Guaranty Agreement”).

    The Canadian Borrowers may elect to have borrowings either in United States dollars or Canadian dollars under the Canadian Loan Agreement, which will bear interest at a base rate or SOFR, in each case, plus an applicable margin, in the case of borrowings in United States dollars, or at a Canadian Prime Rate (as announced from time to time by PNC Canada) or a Canadian deposit offered rate (“CDOR”) as determined from time to time by PNC Canada in accordance with the Canadian Loan Agreement. The applicable margin for these borrowings range from 0.50% to 1.50% per annum, in the case of base rate borrowings and Canadian Prime Rate borrowings, and 1.50% to 2.50% per annum, in the case of SOFR borrowings and CDOR borrowings. The Canadian Loan Agreement also requires the Canadian Borrowers to pay (i) an unused line fee on the unused portion of the loan commitments in an amount ranging between 0.175% and 0.25% per annum, based upon the level of the Company’s consolidated total net leverage ratio, and (ii) an upfront fee equal to 0.25% of the principal amount of the Note.

    The Canadian Loan Agreement also contains customary representations and warranties, and affirmative and negative covenants, including, among others, limitations on additional indebtedness, entry into new lines of business, entry into guarantee agreements, making of any loans or advances to, or investments in, any other person, restrictions on liens on the assets of the Canadian Borrowers and mergers, transfers of assets and acquisitions. The Canadian Loan Agreement and Note also contain customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions.

    20

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the Canadian Loan Agreement may be accelerated.

    There were no amounts outstanding under the Revolving Canadian Loan as of March 31, 2025 and December 31, 2024.

    7.    DERIVATIVE INSTRUMENTS

    Interest Rate Swaps

    We entered into interest rate swap agreements to hedge forecasted monthly interest rate payments on our floating rate debt. Under the terms of the interest rate swap agreements (“Swap Agreements”), we receive payments based on the 1-month SOFR (4.32% as of March 31, 2025). We had the following Swap Agreements as of March 31, 2025:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Effective Date

        

    Notional Amount

        

    Fixed Rate

    September 30, 2021 through July 23, 2026

    ​

    $

    82,500

    ​

    0.812

    %

    May 31, 2023 through July 23, 2026

    ​

    $

    45,000

        

    3.905

    %

    February 14, 2025 through December 20, 2029

        

    $

    38,883

        

    4.080

    %

    ​

    During the three months ended March 31, 2025, there were no Swap Agreements that expired.

    We designated the Swap Agreements as cash flow hedges. A portion of the amount included in accumulated other comprehensive loss is reclassified into interest expense, net as a yield adjustment as interest is either paid or received on the hedged debt. The fair value of our Swap Agreements is based upon Level 2 inputs. We have considered our own credit risk and the credit risk of the counterparties when determining the fair value of our Swap Agreements.

    It is our policy to execute such instruments with creditworthy banks and not to enter into derivative financial instruments for speculative purposes. We believe our interest rate swap counterparty will be able to fulfill their obligations under our agreements, and we believe we will have debt outstanding through the expiration date of the swap agreements such that the occurrence of future cash flow hedges remains probable.

    The estimated fair value of our Swap Agreements in the condensed consolidated balance sheets was as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Balance Sheet Accounts

    ​

    March 31, 2025

        

    December 31, 2024

    Other current assets

    ​

    $

    2,479

    ​

    $

    2,749

    Other assets

    ​

    $

    616

    ​

    $

    1,298

    Accrued liabilities

    ​

    $

    63

    ​

    $

    —

    Other liabilities

    ​

    $

    707

    ​

    $

    —

    ​

    A cumulative gain, net of tax, of $1,645 and $2,917 is recorded in accumulated other comprehensive loss as of March 31, 2025 and December 31, 2024, respectively.

    The amount of loss, net of tax, recognized in other comprehensive (loss) income for the three months ended March 31, 2025 and 2024 was $695 and $1,568, respectively. There was a gain, net of tax, of $577 and $872 reclassified from accumulated other comprehensive loss into earnings for the three months ended March 31, 2025 and 2024, respectively.

    As of March 31, 2025, approximately $2,318 is expected to be reclassified from accumulated other comprehensive loss into interest expense over the next 12 months.

    21

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    Foreign Currency Hedge

    We entered into forward contracts to hedge forecasted Mexican Peso (“MXN”) denominated costs associated with our Mexican subsidiary. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are recorded in other comprehensive (loss) income and are reclassified from accumulated other comprehensive loss into earnings in the period the hedged item impacts earnings.

    As of March 31, 2025, the Company had outstanding contracts with a total notional amount of $94,313 MXN and recognized a cumulative loss, net of tax, of $55 in accumulated other comprehensive loss.

    The Company recognized a loss, net of tax, of $55 and a gain, net of tax, of $92 in other comprehensive (loss) income for the three months ended March 31, 2025 and 2024, respectively. There was a loss, net of tax, of $314 and $22 reclassified from accumulated other comprehensive loss into earnings for the three months ended March 31, 2025 and 2024, respectively.

    As of March 31, 2025, approximately $55 is expected to be reclassified from accumulated other comprehensive loss into earnings over the next 12 months.

    8.    COMMITMENTS AND CONTINGENCIES

    Legal Proceedings

    The Company is also involved in various legal disputes and other legal proceedings and claims that arise from time to time in the ordinary course of business. The Company vigorously defends itself against all lawsuits and evaluates the amount of reasonably possible losses that the Company could incur as a result of these matters. While any litigation contains an element of uncertainty, the Company believes that the reasonably possible losses that the Company could incur in excess of insurance coverage would not have a material adverse effect on the Company’s consolidated financial position, results of operations, or liquidity.

    Insurance

    The Company has various insurance policies, including product liability insurance, covering risks and in amounts it considers adequate. There can be no assurance that the insurance coverage maintained by the Company is sufficient or will be available in adequate amounts or at a reasonable cost.

    International

    As an international company, we are, from time to time, the subject of investigations related to the Company’s international operations, including under U.S. export control laws (such as ITAR), the FCPA and other similar U.S. and foreign laws. To the best of the Company’s knowledge, there are not any potential or pending investigations at this time.

    9.    INCOME TAXES

    The Company and its subsidiaries file income tax returns in the U.S. federal, various state and local, and certain foreign jurisdictions. As of March 31, 2025, the Company’s tax years subsequent to 2017 are subject to examination by tax authorities with few exceptions.

    The effective tax rate was 26.6% for the three months ended March 31, 2025 and was higher than the statutory rate primarily due to state taxes and non-deductible executive compensation. The effective tax rate was 22.1% for the three months ended March 31, 2024 and was lower than the statutory rate primarily due to the vesting of stock compensation, partially offset by non-deductible executive compensation.

    22

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    10.     LEASES

    The Company leases certain manufacturing and office space, retail locations, and equipment. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The Company has elected the practical expedient and does not recognize a lease liability or right-of-use (“ROU”) asset for short-term leases (leases with a term of twelve months or less). The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is the rate for collateralized borrowings based on the current economic environment, credit history, credit rating, value of leases, currency in which the lease obligation is satisfied, rate sensitivity, lease term and materiality. Our operating leases have remaining contractual terms of up to five years, some of which include options to extend the leases for up to five years.

    The amount of assets and liabilities related to our operating leases were as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Balance Sheet Accounts

    ​

    March 31, 2025

        

    December 31, 2024

    Assets:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Operating lease assets

    Operating lease assets

    ​

    $

    15,595

    ​

    $

    15,454

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Liabilities:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Current:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Operating lease liabilities

    Accrued liabilities

    ​

    $

    4,721

    ​

    $

    4,824

    Long-term:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Operating lease liabilities

    Long-term operating lease liabilities

    ​

    ​

    10,983

    ​

    ​

    10,733

    Total lease liabilities

    ​

    ​

    $

    15,704

    ​

    $

    15,557

    ​

    The components of lease expense are recorded to cost of sales and selling, general and administration expenses in the condensed consolidated statements of operations and comprehensive income. The components of lease expense were as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

        

    2025

        

    2024

    Fixed operating lease costs(1)

    ​

    $

    1,420

    ​

    $

    1,149

    Variable operating lease costs

    ​

     

    410

    ​

     

    255

    Total

    ​

    $

    1,830

    ​

    $

    1,404

    (1) Includes short-term leases, which are immaterial.

    The weighted average remaining lease term and weighted average discount rate is as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

        

    December 31, 2024

    Weighted average remaining lease term (years):

     

    ​

    ​

     

    ​

    ​

    Operating leases

    ​

    ​

    3.52

    ​

    ​

    3.07

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Weighted average discount rate:

    ​

    ​

    ​

    ​

    ​

    ​

    Operating leases

    ​

    ​

    3.19%

    ​

    ​

    3.14%

    ​

    23

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    The estimated future minimum lease payments under operating leases for the remaining nine months of 2025, the next four years and thereafter is as follows:

    ​

    ​

    ​

    ​

    ​

    Remainder of 2025

    ​

    $

    3,900

    2026

    ​

     

    4,554

    2027

    ​

     

    3,474

    2028

    ​

     

    2,513

    2029

    ​

     

    1,539

    Thereafter

    ​

     

    1,145

    Total future lease payments

    ​

    ​

    17,125

    Less: Amount representing interest

    ​

    ​

    (1,421)

    Present value of lease liabilities

    ​

    $

    15,704

    ​

    Supplemental cash flow information related to leases is as follows:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 

    ​

    ​

    2025

        

    2024

    Cash paid for amounts included in the measurement of lease liabilities:

     

    ​

    ​

     

    ​

    ​

    Operating cash flows - operating leases

    ​

    $

    1,476

    ​

    $

    1,073

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Right-of-use assets obtained in exchange for lease liabilities:

    ​

    ​

    ​

    ​

    ​

    ​

    Operating leases

    ​

    $

    1,940

    ​

    $

    1,349

    ​

    ​

    11.     RELATED PARTY TRANSACTIONS

    The Company leases some distribution warehouses and retail stores from certain employees. The Company recorded rent expense related to these leases of $128 and $93 for the three months ended March 31, 2025 and 2024, respectively. Rent expense related to these leases is included in related party expense in the Company’s condensed consolidated statements of operations and comprehensive income.

    During the three months ended March 31, 2024, the Company paid $1,750 to Kanders & Company, Inc., a company controlled by Warren B. Kanders, our Chief Executive Officer, for services related to the acquisition of Alpha Safety, which is included in related party expense in the Company’s condensed consolidated statements of operations and comprehensive income.

    There were no payments made to Kanders & Company, Inc. for the three months ended March 31, 2025.

    12.     SEGMENT DATA

    Our segment disclosure is intended to provide the users of our consolidated financial statements with a view of the business that is consistent with management of the Company.

    Our operations are comprised of two operating and reportable segments: Product and Distribution. The Product segment is comprised of components that manufacture and sell products, while the Distribution segment is comprised of our business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products. Segment information is consistent with how the chief operating decision maker (“CODM”), our chief executive officer, reviews the business, makes investing and resource allocation decisions and assesses operating performance. The CODM evaluates segment performance and

    24

    Table of Contents

    CADRE HOLDINGS, INC.

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

    (Unaudited)

    (in thousands, except share and per share amounts)

    decides how to allocate resources based on segment gross profit. The CODM is not regularly provided asset information or operating expenses by segment as that information is not available.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 2025

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Reconciling

    ​

    ​

    ​

    ​

        

        Product    

        

    Distribution

        

     Items(1)

        

          Total      

    Net sales

        

    $

    112,735

    ​

    $

    27,862

    ​

    $

    (10,491)

        

    $

    130,106

    Cost of goods sold

    ​

    ​

    62,625

    ​

    ​

    21,841

    ​

    ​

    (10,491)

    ​

    ​

    73,975

    Gross profit

    ​

    $

    50,110

    ​

    $

    6,021

    ​

    $

    —

    ​

    $

    56,131

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 2024

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Reconciling

    ​

    ​

    ​

    ​

        

        Product    

        

    Distribution

        

     Items(1)

        

          Total      

    Net sales

        

    $

    118,785

    ​

    $

    28,191

    ​

    $

    (9,116)

        

    $

    137,860

    Cost of goods sold

    ​

    ​

    67,764

    ​

    ​

    21,557

    ​

    ​

    (9,089)

    ​

    ​

    80,232

    Gross profit

    ​

    $

    51,021

    ​

    $

    6,634

    ​

    $

    (27)

    ​

    $

    57,628

    (1) Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    ​

    13.     SUBSEQUENT EVENTS

    Acquisition

    In April 2025, the Company acquired Carr’s Engineering Limited (excluding Chirton Engineering) and Carr's Engineering (US), Inc. (together the “Nuclear Engineering Division”), each a subsidiary of Carr’s Group plc, for approximately $99,750.

    The acquisition will be accounted for using the acquisition method of accounting whereby the acquired assets and liabilities of the acquired companies will be recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets. Results of operations of the acquired companies will be included in the operations of the Company beginning on the closing date. As of the date of the filing of this Form 10-Q, the initial purchase price allocation has not been prepared as there has not been sufficient time to complete the related activities.

    Long-Term Debt

    In April 2025, in connection with the acquisition of the Nuclear Engineering Division, the Company drew $97,500 of the $115,000 available under the DDTL- A-1 Facility. The DDTL- A-1 Facility has the same terms and conditions as the 2024 Term Loan including such items as interest rate, quarterly amortization payment requirements, and maturity date.

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    25

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

    The following discussion and analysis of the financial condition and results of operations of Cadre Holdings, Inc. (D/B/A The Safariland Group) (“Cadre,” “the Company” “we,” “us” and “our”) should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of Cadre’s control. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ materially from those projected in the forward- looking statements include, but are not limited to, those discussed in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2024 and the section entitled “Cautionary Statement Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q.

    Our Business

    Cadre is a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment and duty gear through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providing equipment we manufacture as well as third-party products including uniforms, optics, boots, firearms and ammunition. The majority of our diversified product offering is governed by rigorous safety standards and regulations. Demand for our products is driven by technological advancement as well as recurring modernization and replacement cycles for the equipment to maintain its efficiency, effective performance and regulatory compliance.

    We service the ever-changing needs of our end users by investing in research and development for new product innovation and technical advancements that continually raise the standards for safety equipment. Our target end user base includes domestic and international first responders such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections and numerous foreign government agencies in over 100 countries.

    The following table sets forth a summary of our financial highlights for the periods indicated:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    (in thousands)

    ​

    2025

    ​

    2024

    Net sales

        

    $

    130,106

        

    $

    137,860

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    Adjusted EBITDA(1)

    ​

    $

    20,497

    ​

    $

    24,488

    (1)Adjusted EBITDA is a non-GAAP financial measure. See “Non-GAAP Measures” below for our definition of, and additional information about, Adjusted EBITDA, and for a reconciliation to net income, the most directly comparable U.S. GAAP financial measure.

    Net sales decreased by $7.8 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily as a result of a decrease in explosive ordnance disposal (“EOD”) and armor products, partially offset by increases from recent acquisitions and international crowd control products.

    26

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    Net income increased by $2.3 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily as a result of the non-recurrence of acquisition related costs incurred in 2024.

    KEY PERFORMANCE METRICS

    Orders backlog

    We monitor our orders backlog, which we believe is a forward-looking indicator of potential sales. Our orders backlog for products includes all orders that have been received and are believed to be firm. Due to municipal government procurement rules, in certain cases orders included in backlog are subject to budget appropriation or other contract cancellation clauses. Consequently, our orders backlog may differ from actual future sales. Orders backlog can be helpful to investors in evaluating the performance of our business and identifying trends over time.

    The following table presents our orders backlog as of the periods indicated:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    March 31, 2025

    ​

    December 31, 2024

    Orders backlog

    ​

    $

    151,185

    ​

    $

    128,814

    ​

    Orders comprising backlog as of a given balance sheet date are typically invoiced in subsequent periods. The majority of our products are generally processed and shipped within one to three weeks of an order being placed, though the fulfillment time for certain products, for example, explosive ordnance disposal equipment, may take three months or longer. Our orders backlog could experience volatility between periods, including as a result of customer order volumes and the speed of our order fulfilment, which in turn may be impacted by the nature of products ordered, the amount of inventory on hand and the necessary manufacturing lead time.

    Orders backlog increased by $22.4 million as of March 31, 2025 compared to December 31, 2024, primarily due to increases of $10.6 million from EOD products, $6.6 million from chemiluminescent products, $2.8 million from duty gear products, and $2.2 million from structural armor products, partially offset by a reduction of $1.4 million from delivery of large international crowd control orders.

    ​

    27

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    RESULTS OF OPERATIONS

    In order to reflect the way our chief operating decision maker reviews and assesses the performance of the business, Cadre has determined that it has two reportable segments — the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of our business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products. Segment information is consistent with how the chief operating decision maker, our chief executive officer, reviews the business, makes investing and resource allocation decisions and assesses operating performance.

    The following table presents data from our results of operations for the three months ended March 31, 2025 and 2024 (in thousands unless otherwise noted):

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Three Months Ended March 31, 

    ​

    ​

    ​

    ​

    ​

    2025

    ​

    2024

    ​

    % Chg

    ​

    Net sales

    ​

    $

    130,106

    ​

    $

    137,860

    ​

    (5.6)

    %

    Cost of goods sold

    ​

     

    73,975

    ​

     

    80,232

    ​

    (7.8)

    %

    Gross profit

    ​

     

    56,131

    ​

     

    57,628

    ​

    (2.6)

    %

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Operating expenses

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Selling, general and administrative

    ​

     

    41,753

    ​

     

    40,719

    ​

    2.5

    %

    Restructuring and transaction costs

    ​

     

    698

    ​

     

    3,087

    ​

    (77.4)

    %

    Related party expense

    ​

     

    128

    ​

     

    1,843

    ​

    (93.1)

    %

    Total operating expenses

    ​

     

    42,579

    ​

     

    45,649

    ​

    (6.7)

    %

    Operating income

    ​

     

    13,552

    ​

     

    11,979

    ​

    13.1

    %

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Other expense

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Interest expense

    ​

     

    (2,231)

    ​

     

    (1,637)

    ​

    36.3

    %

    Other income (expense), net

    ​

     

    1,287

    ​

     

    (1,444)

    ​

    (189.1)

    %

    Total other expense, net

    ​

     

    (944)

    ​

     

    (3,081)

    ​

    (69.4)

    %

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Income before provision for income taxes

    ​

     

    12,608

    ​

     

    8,898

    ​

    41.7

    %

    Provision for income taxes

    ​

     

    (3,360)

    ​

     

    (1,970)

    ​

    70.6

    %

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    ​

    33.5

    %

    ​

    The following tables present segment data for the three months ended March 31, 2025 and 2024 (in thousands):

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 2025

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Reconciling

    ​

    ​

    ​

    ​

        

        Product    

        

    Distribution

        

     Items(1)

        

          Total      

    Net sales

        

    $

    112,735

    ​

    $

    27,862

    ​

    $

    (10,491)

        

    $

    130,106

    Cost of goods sold

    ​

    ​

    62,625

    ​

    ​

    21,841

    ​

    ​

    (10,491)

    ​

    ​

    73,975

    Gross profit

    ​

    $

    50,110

    ​

    $

    6,021

    ​

    $

    —

    ​

    $

    56,131

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 2024

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Reconciling

    ​

    ​

    ​

    ​

        

        Product    

        

    Distribution

        

     Items(1)

        

          Total      

    Net sales

        

    $

    118,785

    ​

    $

    28,191

    ​

    $

    (9,116)

        

    $

    137,860

    Cost of goods sold

    ​

    ​

    67,764

    ​

    ​

    21,557

    ​

    ​

    (9,089)

    ​

    ​

    80,232

    Gross profit

    ​

    $

    51,021

    ​

    $

    6,634

    ​

    $

    (27)

    ​

    $

    57,628

    (1) Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    28

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    Comparison of Three months Ended March 31, 2025 to Three months Ended March 31, 2024

    Net sales. Product segment net sales decreased by $6.1 million, or 5.1%, from $118.8 million to $112.7 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreases of $8.7 million from EOD products and $7.2 million from armor products, both from large orders delivered in 2024, partially offset by increases of $9.1 million from recent acquisitions and $1.4 million from international crowd control products. Distribution segment net sales decreased by $0.3 million, or 1.2%, from $28.2 million to $27.9 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreased demand for hard goods. Reconciling items consisting primarily of intercompany eliminations were $10.5 million and $9.1 million for the three months ended March 31, 2025 and 2024, respectively.

    Cost of goods sold and gross profit. Product segment cost of goods sold decreased by $5.2 million, or 7.6%, from $67.8 million to $62.6 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to decreased volumes and the absence of inventory step-up amortization, partially offset by increased costs to manufacture product. Product segment gross profit as a percentage of net sales increased by 150 basis points to 44.4% for the three months ended March 31, 2025 from 43.0% for the three months ended March 31, 2024, mainly driven by favorable mix, favorable pricing net of material inflation and the absence of inventory step-up amortization, partially offset by lower volumes. Distribution segment cost of goods sold increased by $0.2 million, or 1.3%, from $21.6 million to $21.8 million for the three months ended March 31, 2025 as compared to the same period in 2024, primarily due to unfavorable mix. Distribution segment gross profit as a percentage of net sales decreased by 192 basis points to 21.6% for the three months ended March 31, 2025 from 23.5% for the three months ended March 31, 2024, mainly driven by unfavorable mix. Reconciling items consisting primarily of intercompany eliminations were $10.5 million and $9.1 million for the three months ended March 31, 2025 and 2024, respectively.

    Selling, general and administrative. Selling, general and administrative increased by $1.0 million, or 2.5%, for the three months ended March 31, 2025 as compared to the same period in 2024, primarily due to recent acquisitions.

    Restructuring and transaction costs. Restructuring and transaction costs decreased by $2.4 million for the three months ended March 31, 2025 primarily due to costs incurred in 2024 associated with the ICOR and Alpha Safety acquisitions.

    Related party expense. Related party expense, which ordinarily consists of rent expense related to distribution warehouses and retail stores that we lease from related parties, decreased by $1.7 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024 primarily due to a $1.8 million transaction fee paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, in connection with the acquisition of Alpha Safety.

    Interest expense. Interest expense increased by $0.6 million for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, primarily due to the debt refinancing that occurred in the fourth quarter of 2024.

    Other income (expense), net. Other income, net was $1.3 million for the three months ended March 31, 2025 as compared to Other expense, net of $1.4 million for the three months ended March 31, 2024, primarily due to changes in foreign currency exchange rates.

    Provision for income taxes. Provision for income taxes was $3.4 million for the three months ended March 31, 2025 compared to $2.0 million for the three months ended March 31, 2024. The effective tax rate was 26.6% for the three months ended March 31, 2025 and was higher than the statutory rate primarily due to state taxes and non-deductible executive compensation. The effective tax rate was 22.1% for the three months ended March 31, 2024 and was lower than the statutory rate primarily due to the vesting of stock compensation, partially offset by non-deductible executive compensation.

    NON-GAAP MEASURES

    This Quarterly Report on Form 10-Q includes EBITDA and Adjusted EBITDA, which are non-GAAP financial measures that we use to supplement our results presented in accordance with U.S. GAAP. EBITDA is defined as net income before depreciation and amortization expense, interest expense and provision for income tax. Adjusted EBITDA represents EBITDA that excludes

    29

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    restructuring and transaction costs, other (income) expense, net, stock-based compensation expense, stock-based compensation payroll tax expense, long-term incentive plan (“LTIP”) bonus, amortization of inventory step-up and contingent consideration expense as these items do not represent our core operating performance.

    EBITDA and Adjusted EBITDA are performance measures that we believe are useful to investors and analysts because they illustrate the underlying financial and business trends relating to our core, recurring results of operations and enhance comparability between periods. Adjusted EBITDA is considered by our board of directors and management as an important factor in determining performance-based compensation.

    EBITDA and Adjusted EBITDA are not recognized measures under U.S. GAAP and are not intended to be a substitute for any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly-titled measures of performance of other companies. Investors should exercise caution in comparing our non-GAAP measures to any similarly titled measures used by other companies. These non-GAAP financial measures exclude certain items required by U.S. GAAP and should not be considered as alternatives to information reported in accordance with U.S. GAAP.

    The table below presents our EBITDA and Adjusted EBITDA reconciled to the most comparable GAAP financial measures for the periods indicated:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 

    (in thousands)

        

    2025

        

    2024

    Net income

    ​

    $

    9,248

    ​

    $

    6,928

    Add back:

    ​

     

      

      

     

      

    Depreciation and amortization

    ​

     

    3,856

      

     

    3,942

    Interest expense

    ​

     

    2,231

      

     

    1,637

    Provision for income taxes

    ​

     

    3,360

      

     

    1,970

    EBITDA

    ​

    $

    18,695

      

    $

    14,477

    Add back:

    ​

     

      

      

     

      

    Restructuring and transaction costs(1)

    ​

     

    698

      

     

    4,837

    Other (income) expense, net(2)

    ​

     

    (1,287)

      

     

    1,444

    Stock-based compensation expense(3)

    ​

    ​

    1,968

    ​

    ​

    2,067

    Stock-based compensation payroll tax expense(4)

    ​

    ​

    92

    ​

    ​

    393

    LTIP bonus(5)

    ​

     

    —

      

     

    50

    Amortization of inventory step-up(6)

    ​

    ​

    —

    ​

    ​

    769

    Contingent consideration expense(7)

    ​

    ​

    331

    ​

    ​

    451

    Adjusted EBITDA

    ​

    $

    20,497

      

    $

    24,488

    (1)Reflects the “Restructuring and transaction costs” line item on our condensed consolidated statements of operations and comprehensive income, which primarily includes transaction costs composed of legal and consulting fees, and $1.8 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Alpha Safety, which is included in related party expense in the Company’s condensed consolidated statements of operations and comprehensive income for the three months ended March 31, 2024.
    (2)Reflects the “Other income (expense), net” line item on our condensed consolidated statement of operations and comprehensive income, and primarily includes gains and losses due to fluctuations in foreign currency exchange rates.
    (3)Reflects compensation expense related to equity classified stock-based compensation plans.
    (4)Reflects payroll taxes associated with vested stock-based compensation awards.
    (5)Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    30

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    (6)Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.
    (7)Reflects contingent consideration expense related to the acquisition of ICOR.

    Adjusted EBITDA decreased by $4.0 million for the three months ended March 31, 2025 as compared to 2024, primarily due to lower sales volume partially offset by favorable pricing net of material inflation, favorable mix, and the absence of inventory step-up amortization.

    LIQUIDITY AND CAPITAL RESOURCES

    Liquidity refers to our ability to generate sufficient cash flows to meet the cash requirements of our business operations, including working capital needs, capital expenditures, debt service, acquisitions and other commitments. Our principal sources of liquidity have been cash provided by operating activities, cash on hand and amounts available under our revolving loans.

    For the three months ended March 31, 2025, net cash provided by operating activities totaled $17.4 million and as of March 31, 2025, cash and cash equivalents totaled $133.4 million. We believe that our cash flows from operations and cash on hand, and available borrowing capacity under our existing credit facilities (as described below) will be adequate to meet our liquidity requirements for at least the 12 months following the date of this Quarterly Report on Form 10-Q. Our future capital requirements will depend on several factors, including future acquisitions and investments in our manufacturing facilities and equipment. We could be required, or could elect, to seek additional funding through public or private equity or debt financings; however, additional funds may not be available on terms acceptable to us, if at all.

    Debt

    As of March 31, 2025 and December 31, 2024, we had $220.5 million and $223.2 million in outstanding debt, net of debt discounts and debt issuance costs, respectively, primarily related to the term loan facilities.

    2024 Credit Agreement

    On December 20, 2024 (the “2024 Credit Agreement Closing Date”), the Company refinanced its existing credit facilities and entered into an Amended and Restated Credit Agreement (the “2024 Credit Agreement”), whereby Safariland, LLC, as borrower (the “2024 Borrower”), the Company, and certain domestic subsidiaries of the 2024 Borrower, as guarantors (the “2024 Guarantors”), closed on and received funding under the 2024 Credit Agreement with PNC, as administrative agent, swingline lender, and issuing lender, along with several other lenders (collectively, the “2024 Lenders”). The 2024 Credit Agreement amends and restates the 2021 Credit Agreement in its entirety.

    Pursuant to the 2024 Credit Agreement, the 2024 Borrower (i) borrowed $225.0 million under a term loan facility (the “2024 Term Loans”), (ii) may borrow up to $175.0 million under a revolving credit facility (the “2024 Revolving Loan”), including up to $30.0 million for letters of credit and up to $10.0 million for swingline loans, (iii) may borrow up to $115.0 million under a delayed draw term loan A-1 facility (the “DDTL A-1 Facility”) available through June 20, 2025, and (iv) may borrow up to $75.0 million under a delayed draw term loan A-2 facility (the “DDTL A-2 Facility”) available through June 20, 2026. Each of these facilities matures on December 20, 2029. The proceeds of the 2024 Term Loans were used to refinance the outstanding term loans under the 2021 Credit Agreement and to pay fees and expenses incurred in connection with entering into the 2024 Credit Agreement. The 2024 Credit Agreement also permits the 2024 Borrower, subject to certain requirements, to arrange with lenders for an aggregate of $100.0 million (or more if certain leverage ratios are met) of additional revolving and/or term loan commitments (both of which are currently uncommitted).

    The 2024 Borrower may elect to have borrowings under the 2024 Credit Agreement bear interest at either (i) a base rate plus an applicable margin ranging from 0.50% to 1.50% per annum or (ii) a term SOFR rate plus an applicable margin ranging from 1.50% to 2.50% per annum, in each case based on the Company’s consolidated total net leverage ratio. The 2024 Borrower is also required to

    31

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    pay a commitment fee on the unused portion of the 2024 Revolving Loan, the DDTL A-1 Facility, and the DDTL A-2 Facility, ranging from 0.175% to 0.25% per annum, based on the Company’s consolidated total net leverage ratio.

    The 2024 Term Loans require scheduled quarterly principal payments of 1.25% of the original aggregate principal amount, beginning March 31, 2025, with the balance due at maturity.

    The 2024 Credit Agreement is guaranteed, jointly and severally, by the 2024 Guarantors and, subject to certain exceptions, secured by a first-priority security interest in substantially all of the assets of the 2024 Borrower and the 2024 Guarantors pursuant to an Amended and Restated Security and Pledge Agreement and an Amended and Restated Guaranty and Suretyship Agreement, each dated as of the 2024 Credit Agreement Closing Date.

    The 2024 Credit Agreement contains customary representations and warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the 2024 Borrower or any 2024 Guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, dispositions, and mandatory prepayments in connection with certain liquidity events. Additionally, the 2024 Credit Agreement contains certain restrictive debt covenants, which require us to: (i) maintain a minimum fixed charge coverage ratio of 1.25 to 1.00, starting with the quarter ended December 31, 2024, which is to be determined for each quarter end on a trailing four quarter basis and (ii) maintain a quarterly maximum consolidated total net leverage ratio of 4.00 to 1.00 from the quarter ended December 31, 2024 until the quarter ended March 31, 2026, and thereafter 3.50 to 1.00, which is in each case to be determined on a trailing four quarter basis; provided that under certain circumstances and subject to certain limitations, in the event of a material acquisition, we may temporarily increase the consolidated total net leverage ratio by up to 0.50 to 1.00 for four fiscal quarters following such acquisition, subject to a maximum consolidated total net leverage ratio of 4.00 to 1.00. Furthermore, the 2024 Credit Agreement also includes customary events of default, including non-payment of principal, interest, or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payments on other material indebtedness, bankruptcy and insolvency events, material judgments, and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the 2024 Credit Agreement may be accelerated, and the Lenders could foreclose on their security interests in the assets of the Borrower and the Guarantors. As of May 2, 2025, there were no amounts outstanding under the Revolving Loan.

    The foregoing description of the 2024 Credit Agreement does not purport to be complete and is qualified in its entirety by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on December 23, 2024, and is incorporated herein by reference as though fully set forth herein.

    There were no amounts outstanding under the 2024 Revolving Loan as of March 31, 2025 and December 31, 2024. As of March 31, 2025, there were $2.2 million in outstanding letters of credit and $172.8 million of availability.

    Canadian Credit Facility

    On October 14, 2021, Med-Eng Holdings ULC and Pacific Safety Products Inc., the Company’s Canadian subsidiaries, as borrowers (the “Canadian Borrowers”), and Safariland, LLC, as guarantor (the “Canadian Guarantor”), closed on a line of credit pursuant to a Loan Agreement (the “Canadian Loan Agreement”) and a Revolving Line of Credit Note (the “Note”) with PNC Bank Canada Branch (“PNC Canada”), as lender pursuant to which the Canadian Borrowers may borrow up to CDN$10.0 million under a revolving line of credit (including up to $3.0 million for letters of credit) (the “Revolving Canadian Loan”). The Revolving Canadian Loan matures on July 23, 2026. The Canadian Loan Agreement is guaranteed by the Canadian Guarantor pursuant to a Guaranty and Suretyship Agreement.

    The Canadian Borrowers may elect to have borrowings either in United States dollars or Canadian dollars under the Canadian Loan Agreement, which will bear interest at a base rate or SOFR, in each case, plus an applicable margin, in the case of borrowings in United States dollars, or at a Canadian Prime Rate (as announced from time to time by PNC Canada) or a Canadian deposit offered rate (“CDOR”) as determined from time to time by PNC Canada in accordance with the Canadian Loan Agreement. The applicable

    32

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    margin for these borrowings will range from 0.50% to 1.50% per annum, in the case of base rate borrowings and Canadian Prime Rate borrowings, and 1.50% to 2.50% per annum, in the case of SOFR borrowings and CDOR borrowings. The Canadian Loan Agreement also requires the Canadian Borrowers to pay (i) an unused line fee on the unused portion of the loan commitments in an amount ranging between 0.175% and 0.25% per annum, based upon the level of the Company’s consolidated total net leverage ratio, and (ii) an upfront fee equal to 0.25% of the principal amount of the Note.

    There were no amounts outstanding under the Revolving Canadian Loan as of March 31, 2025 and December 31, 2024.

    The Canadian Loan Agreement also contains customary representations and warranties, and affirmative and negative covenants, including, among others, limitations on additional indebtedness, entry into new lines of business, entry into guarantee agreements, making of any loans or advances to, or investments in, any other person, restrictions on liens on the assets of the Canadian Borrowers and mergers, transfers of assets and acquisitions. The Canadian Loan Agreement and Note also contain customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the Canadian Loan Agreement may be accelerated. As of May 2, 2025, there were no amounts outstanding under the Revolving Canadian Loan.

    The foregoing description of the Canadian Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the Canadian Loan Agreement, which is exhibit 10.18 to our Annual Report on Form 10-K for the year ended December 31, 2022, and is incorporated herein by reference as though fully set forth herein.

    Cash Flows

    The following table presents a summary of our cash flows for the periods indicated:

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

        

    Three Months Ended March 31, 

    (in thousands)

        

    2025

        

    2024

    Net cash provided by operating activities

    ​

    $

    17,391

      

    $

    2,137

    Net cash used in investing activities

    ​

     

    (1,309)

      

     

    (142,636)

    Net cash (used in) provided by financing activities

    ​

     

    (7,812)

      

     

    139,786

    Effects of foreign exchange rates on cash and cash equivalents

    ​

     

    228

      

     

    74

    Change in cash and cash equivalents

    ​

     

    8,498

      

     

    (639)

    Cash and cash equivalents, beginning of period

    ​

     

    124,933

      

     

    87,691

    Cash and cash equivalents, end of period

    ​

    $

    133,431

      

    $

    87,052

    ​

    Net cash provided by operating activities

    During the three months ended March 31, 2025, net cash provided by operating activities of $17.4 million resulted primarily from net income of $9.2 million, a $3.9 million add-back to net income for depreciation and amortization, a $2.0 million add-back to net income for stock-based compensation, and a net add-back to net income of $1.6 million for changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily driven by a decrease in accounts receivable of $10.6 million and an increase in inventories of $9.1 million.

    During the three months ended March 31, 2024, net cash provided by operating activities of $2.1 million resulted primarily from net income of $6.9 million, a $3.9 million add back to net income for depreciation and amortization, a $2.1 million add-back to net income for stock-based compensation and a net deduction to net income of $15.2 million for changes in operating assets and liabilities. Changes in operating assets and liabilities were primarily driven by a decrease in accounts payable and other liabilities of $21.7 million, a decrease in accounts receivable of $2.7 million and a decrease in prepaid expenses and other assets of $2.0 million.

    33

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    Net cash used in investing activities

    During the three months ended March 31, 2025, we used $1.3 million of cash in investing activities for the purchase of property and equipment.

    During the three months ended March 31, 2024, we used $142.6 million of cash in investing activities, primarily consisting of $141.3 million for the acquisition of ICOR and Alpha Safety.

    Net cash (used in) provided by financing activities

    During the three months ended March 31, 2025, we used $7.8 million of cash in financing activities, consisting of principal payments on term loans of $2.8 million, taxes paid in connection with employee stock transactions of $1.1 million and dividends distributed of $3.9 million.

    During the three months ended March 31, 2024, net cash provided by financing activities of $139.8 million resulted primarily from proceeds from term loans of $80.0 million and proceeds from the secondary offering of $73.5 million, partially offset by taxes paid in connection with employee stock transactions of $5.3 million and dividends distributed of $3.3 million.

    Contractual Obligations

    Our long-term contractual obligations generally include our debt and related interest payments and operating and finance lease payments for our property and equipment, and are expected to be funded from cash-on-hand, cash from operations and availability under our existing credit facilities. There were no significant changes to our contractual obligations from those disclosed in the Quarterly Report on Form 10-Q for the three months ended March 31, 2024.

    Off-Balance Sheet Arrangements

    We do not engage in off-balance sheet financing arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

    CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES

    Our condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. Preparation of the financial statements requires us to make judgments, estimates and assumptions that impact the reported amount of net sales and expenses, assets and liabilities and the disclosure of contingent assets and liabilities. We consider an accounting judgment, estimate or assumption to be critical when the estimate or assumption is complex in nature or requires a high degree of judgment and when the use of different judgments, estimates and assumptions could have a material impact on our condensed consolidated financial statements. While our significant accounting policies are described in more detail in notes in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

    There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the year ended December 31, 2024.

    Recently Adopted and Issued Accounting Pronouncements

    Recently issued and adopted accounting pronouncements are described in notes to our audited consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

    34

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    Emerging Growth Company

    We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation or golden parachute arrangements.

    In addition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our condensed consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates.

    ​

    ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

    We have in the past and may in the future be exposed to certain market risks, including interest rate, foreign currency exchange in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial condition or results of operations due to adverse changes in financial market prices and rates. These risks are not significant to our results of operations, but they may be in the future. We do not hold or issue financial instruments for speculative or trading purposes. There have not been material changes in market risk exposures as of March 31, 2025.

    Interest rate risk

    Changes in interest rates affect the amount of interest expense we are required to pay on our floating rate debt. As of March 31, 2025, we had $222.2 million in outstanding floating rate debt, which bears interest at one-month SOFR (4.32% as of March 31, 2025) plus applicable margin.

    We entered into the Swap Agreements to convert a portion of the interest rate exposure on our floating rate debt from variable to fixed and designated them as cash flow hedges. Under the terms of the Swap Agreements, we receive payments based on the 1-month SOFR. A portion of the amount included in accumulated other comprehensive loss is reclassified into interest expense, net as a yield adjustment as interest is either paid or received on the hedged debt. The fair value of our Swap Agreements is based upon Level 2 inputs. We have considered our own credit risk and the credit risk of the counterparties when determining the fair value of our Swap Agreements.

    We performed a sensitivity analysis on the principal amount of debt as of March 31, 2025, as well as the effect of our Swap Agreements. Further, in this sensitivity analysis, the change in interest rates is assumed to be applicable for an entire year. On an annual basis, a change of 100 basis points in the applicable interest rate would cause a change in interest expense of $2.2 million on the principal amount of debt and a $0.6 million change in interest expense when including the effect of our Swap Agreements.

    As of March 31, 2025, we had the following Swap Agreements (in thousands):

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Effective Date

        

    Notional Amount

        

    Fixed Rate

    September 30, 2021 through July 23, 2026

    ​

    $

    82,500

    ​

    0.812

    %

    May 31, 2023 through July 23, 2026

    ​

    $

    45,000

        

    3.905

    %

    February 14, 2025 through December 20, 2029

        

    $

    38,883

        

    4.080

    %

    ​

    During the three months ended March 31, 2025, there were no interest rate swap agreements that expired.

    35

    Table of Contents

    CADRE HOLDINGS, INC.

    MANAGEMENT DISCUSSION AND ANALYSIS

    (in thousands, except share and per share amounts)

    ​

    Foreign currency exchange rate risk

    Our operations are geographically diverse and we are exposed to foreign currency exchange risk, primarily the Canadian dollar and Mexican peso, related to our transactions and our subsidiaries’ balances that are denominated in currencies other than the U.S. dollar, our functional currency.

    The Company has entered into forward contracts to hedge forecasted Mexican peso denominated costs associated with our Mexican subsidiary. These contracts are designated as cash flow hedges to manage foreign currency transaction risk and are measured at fair value and reported as current assets or current liabilities in the condensed consolidated balance sheets. Any changes in the fair value of designated cash flow hedges are recorded in other comprehensive (loss) income and are reclassified from accumulated other comprehensive loss into earnings in the period the hedged item impacts earnings.

    Significant currency fluctuations could impact the comparability of our results of operations between periods. A 10% increase or decrease in the value of the Canadian dollar to the U.S. dollar would have caused our reported net sales to increase or decrease by approximately $0.9 million for the three months ended March 31, 2025. A 10% increase or decrease in the value of the Canadian dollar to the U.S. dollar would have caused our reported net income to increase or decrease by approximately $0.1 million for the three months ended March 31, 2025, excluding unrealized gains or losses from remeasurement. A 10% increase or decrease in the value of the Mexican peso to the U.S. dollar would have caused our reported net income to increase or decrease by approximately $0.5 million for the three months ended March 31, 2025, respectively, excluding unrealized gains or losses from remeasurement and the impact of cash flow hedges.

    ITEM 4. CONTROLS AND PROCEDURES

    Evaluation of Disclosure Controls and Procedures

    The Company’s management carried out an evaluation, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, its principal executive officer and principal financial officer, respectively, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(c) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of March 31, 2025, pursuant to Exchange Act Rule 13a-15. Such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports we file or submit under the Exchange Act is (i) recorded, processed, summarized, evaluated and reported, as applicable, within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to the appropriate management on a basis that permits timely decisions regarding disclosure. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of March 31, 2025 were effective.

    Changes in Internal Control over Financial Reporting

    There has been no change in our internal control over financial reporting that occurred during the three months ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

    Limitations on Effectiveness of Controls and Procedures

    Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls can prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. There are inherent limitations in all control systems, including the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of one or more persons. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential conditions. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.

    ​

    ​

    36

    Table of Contents

    ​

    PART II. OTHER INFORMATION

    ITEM 1. LEGAL PROCEEDINGS

    Refer to Note 8 of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

    ITEM 1A. RISK FACTORS

    There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

    ITEM 5. OTHER INFORMATION

    On March 13, 2025, Warren B. Kanders, the Company’s Chief Executive Officer and Chairman of the Board of Directors, terminated a stock trading plan that had been adopted on December 22, 2024, in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, the trading plan provided for the potential sale of up to 1,000,000 shares of the Company’s common stock, and was scheduled to expire September 30, 2025. No shares were sold under the plan prior to its termination, and no further transactions will occur pursuant to the terminated plan.

    During the three months ended March 31, 2025, no other director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, nor did the Company during such fiscal quarter adopt or terminate any “Rule 10b5-1 trading arrangement”.

    ​

    ​

    ​

    37

    Table of Contents

    ​

    ITEM 6. EXHIBITS

    Exhibit 
    No.

        

    Description

    2.1

    ​

    Share Purchase Agreement, by and among Cadre Holdings, Inc., Zircaloy Holdings, LLC and Carr’s Group Plc, dated January 15, 2025 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed on January 21, 2025).

    10.1

    ​

    Employment Agreement, dated as of January 24, 2025, between Cadre Holdings, Inc. and Brad Williams (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on January 27, 2025).

    10.2

    ​

    Employment Agreement, dated as of January 24, 2025, between Cadre Holdings, Inc. and Blaine Browers (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on January 27, 2025).

    31.1*

    ​

    Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    31.2*

    ​

    Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    32.1**

    ​

    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    32.2**

    ​

    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    101.INS

    ​

    Inline XBRL Instance Document

    101.SCH

    ​

    Inline XBRL Taxonomy Extension Schema Document

    101.CAL

    ​

    Inline XBRL Taxonomy Extension Calculation Linkbase Document

    101.DEF

    ​

    Inline XBRL Taxonomy Extension Definition Linkbase Document

    101.LAB

    ​

    Inline XBRL Taxonomy Extension Label Linkbase Document

    101.PRE

    ​

    Inline XBRL Taxonomy Extension Presentation Linkbase Document

    104

    ​

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

    *

    Filed herewith

    **

    Furnished herewith. The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

    ​

    ​

    38

    Table of Contents

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    ​

    ​

    ​

    CADRE HOLDINGS, INC.

    Date: May 6, 2025

    ​

    By:

    /s/ Warren B. Kanders

    ​

    ​

    Name:

    Warren B. Kanders

    ​

    ​

    Title:

    Chief Executive Officer

    ​

    ​

    ​

    (Principal Executive Officer)

    ​

    ​

    ​

    ​

    Date: May 6, 2025

    ​

    By:

    /s/ Blaine Browers

    ​

    ​

    Name:

    Blaine Browers

    ​

    ​

    Title:

    Chief Financial Officer

    ​

    ​

    ​

    (Principal Financial Officer and Principal Accounting Officer)

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    39

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care